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1 
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2, 3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
The  Panel  on  Food  Additives  and  Nutrient  Sources  added  to  Food  (ANS  Panel)  has  previously 
provided a scientific opinion re-evaluating the safety of Sunset Yellow FCF (E 110) as a food additive 
in the EU and establishing a temporary acceptable daily intake (ADI) of 1 mg/kg bw/day (EFSA ANS 
Panel, 2009). Following a request by the European Commission, the ANS Panel was asked to assess 
newly submitted data from a study conducted as a result of the recommendations contained in the 2009 
opinion. In addition, EFSA was requested to carry out the refined exposure assessment of Sunset 
Yellow FCF. The new information assessed comprised an evaluation of the 28-day study report, the 
data considered by the Joint FAO/WHO Expert Committee on Food Additives (JECFA) in its latest 
evaluation from 2011, and any additional toxicological information that had become available since 
the completion of the previous evaluation by the ANS Panel. The ANS Panel has considered that the 
newly submitted data from the 28-day study and the overall available toxicological database on Sunset 
Yellow FCF provides a basis to revise the established temporary ADI and concluded that, based on the 
NOAEL of 375 mg/kg bw/day from the long-term feeding study in rats and an uncertainty factor of 
100, a new ADI for Sunset Yellow FCF of 4 mg/kg bw/day can be established, in agreement with the 
latest evaluation by JECFA. Exposure estimates for Sunset Yellow FCF based both on the currently 
authorised MPLs and reported use levels provided are well below the new ADI of 4 mg/kg bw/day for 
all population groups. Overall, the Panel concluded that, using data provided by the food industry and 
Member States, the reported uses and use levels of Sunset Yellow FCF (E 110) would not be of safety 
concern.  
© European Food Safety Authority, 2014 
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SUMMARY 
In 2009 the EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS Panel) has 
adopted a scientific opinion on the re-evaluation of Sunset Yellow FCF (E 110) as a food additive in 
the EU. In its opinion, the ANS Panel  established a temporary acceptable daily intake (tADI) of 
1 mg/kg bw/day and requested a 28-day study with Sunset Yellow FCF to be performed in accordance 
with OECD guidelines and with well-defined material, in order to clarify the histopathological changes 
in the testes and the changes in the blood lipid profile observed by Mathur el al. (2005a, 2005b) in rats, 
after  90-day  dietary  exposure  to  Sunset  Yellow  FCF  at  dose  levels  equivalent  to  250  and 
1 500 mg/kg bw/day. 
Following a request from the European Commission, the ANS Panel was asked to deliver a scientific 
opinion on the data generated from a 28-day study conducted as a result of the recommendations 
contained in the 2009 opinion and whether, on the grounds of these new data, the ADI should be 
reconsidered.  
Furthermore, following the conclusions of the 2009 opinion as regards exposure to Sunset Yellow FCF 
(E 110), EFSA was requested to carry out a refined exposure assessment for this food additive. In that 
opinion, the ANS Panel had evaluated the exposure to Sunset Yellow FCF (E 110) on the basis of the 
uses and use levels authorised in the legislation and the reported use levels as provided by industry, 
and concluded that at the maximum reported levels of use of Sunset Yellow FCF, refined intake 
estimates were generally below the temporary ADI of 1 mg/kg bw/day. However, in 1- to 10-year old 
children, the mean and the high percentiles of exposure could be higher than this temporary ADI, at 
the upper end of the range. 
The ANS Panel noted that since the publication of its scientific opinion on the re-evaluation of Sunset 
Yellow FCF for use as a food additive in 2009, an updated evaluation has been completed by the Joint 
FAO/WHO  Expert  Committee  on  Food  Additives  (JECFA)  in  2011  (JECFA,  2011).  In  its  latest 
evaluation,  JECFA  concluded  that  the  ADI  for  Sunset  Yellow  FCF  should  be  increased  from 
2.5 mg/kg bw/day to 4 mg/kg bw/day. Thus, the ANS Panel considered that, in order to fulfil the 
current mandate, the latest evaluation performed by JECFA in 2011 was also to be taken into account 
for the setting of an ADI for this food colour, alongside any other relevant publications that might have 
become available since the publication of the previous scientific opinion.  
The ANS Panel considered the results from a dietary 28-day study in male Hsd:SD® rats performed 
by Product Safety Labs (2012) using levels of Sunset Yellow FCF up to 18 000 mg/kg diet (equivalent 
to 1 475 mg/kg bw/day), and performed according to the current OECD guidelines, and concluded that 
the findings reported by Mathur et al. (2005a, 2005b) on lipid profile and testes histopathology were 
not confirmed. The Panel agreed with the authors of the 28-day study that the NOAEL of this study 
was 18 000 mg/kg diet (equivalent to 1 475 mg/kg bw/day), the highest dose level tested. The Panel 
noted that the material tested in this 28-day study met the EU specifications for Sunset Yellow FCF as 
a food additive. The Panel, based on the data described in its 2009 opinion and the results from this 
new  28-day  study,  concluded  that  the  findings  of  the  Mathur  studies  (2005a,  2005b)  should  be 
disregarded for the risk assessment of Sunset Yellow FCF.  
The ANS Panel also evaluated one unpublished long-term feeding study in mice and two studies in 
rats  provided  by  the  United  States  Food  and  Drug  Administration  (FDA),  which  had  also  been 
considered by JECFA in its latest evaluation from 2011. In the light of the data from these long-term 
feeding studies, the ANS Panel concluded that no carcinogenic potential of Sunset Yellow FCF was 
observed in mice and rats. Based on the occurrence of the adverse effect on pup body weight gain, 
observed during the last part of the lactation in a long-term rat study in the group fed 1.5 % FD&C 
Yellow No. 6 (Sunset Yellow FCF) in the diet, and described in the full reports provided by the FDA, 
the Panel agreed with JECFA that the NOAEL for this study was 0.75 % (equivalent to 375 mg/kg 
bw/day). The Panel considered that, this NOAEL being obtained from a long-term study including an Reconsideration of the temporary ADI and 
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in utero phase, an uncertainty factor of 100 can be applied for the derivation of a new ADI of 4 mg/kg 
bw/day. 
Lastly, the results of an extensive literature search performed on three electronic databases (PubMed, 
Web of Science and Toxnet) and covering the time span between approximately one year before the 
adoption of the opinion on the re-evaluation of Sunset Yellow FCF (i.e. from 1 November 2008) until 
31 December 2013, aiming to retrieve any additional relevant toxicological data, was reviewed by the 
ANS Panel. 
The safety of Sunset Yellow FCF, with particular respect to the data on its metabolism, genotoxicity 
and  carcinogenicity,  had  already  been  reviewed  by  the  ANS  Panel  in  the  context  of  the  recent 
assessment of Allura Red AC and other structurally related sulphonated mono azo dyes (EFSA ANS 
Panel, 2013). The additional extensive literature search did not reveal any new data in addition to those 
already considered in this statement. 
A study was carried out to investigate the effect of oral administration of Amaranth, Sunset Yellow 
FCF  and  Curcumin  on  immunological  responses  (Hashem  et  al.,  2010).  Sunset  Yellow  FCF 
(315 mg/kg bw/day) was administered by gavage to female Sprague Dawley albino rats for 4 weeks. 
The authors stated that Sunset Yellow used at dose of 315 mg/kg bw/day exerted a depressing effect 
on the cellular, but not humoral, immune response. The Panel noted that this study was conducted with 
locally sourced uncharacterised material of unknown purity and did not consider this study suitable for 
risk assessment. 
Oestrogenic activity of Sunset Yellow FCF was demonstrated in an in vitro model system (Axon et al., 
2012). According to EFSA‟s  Scientific Opinion on the hazard assessment of endocrine disruptors 
(EFSA SC, 2013) “the fact that a substance in an in vitro assay is binding to an endocrine receptor, 
then interfering with the intracellular messenger system connecting receptor to target or resulting in 
an  endocrine-related  response  in  a  target  cell,  must  be  taken  as  strong  indication  for  endocrine 
activity. If a suitable animal model provides further indication for an endocrine-related adverse effect, 
this substance should be considered an endocrine disruptor”. However, in long-term studies including 
an in utero phase in mice and rats, no effects on endocrine and reproductive organs were observed. 
Therefore, the results of this in vitro study were not further considered in the risk assessment. 
In  conclusion,  the  newly  submitted  data from  the  28-day  toxicity  study  and  the  overall available 
toxicological database on Sunset Yellow, including long-term studies, provides a basis to revise the 
established temporary ADI. Based on the NOAEL of 375 mg/kg bw/day from the long-term feeding 
study in rats and an uncertainty factor of 100, a new ADI for Sunset Yellow FCF of 4 mg/kg bw/day 
was established. 
A  refined  exposure  assessment  for  Sunset  Yellow  FCF  (E 110)  has  been  performed  taking  into 
consideration the  Maximum  Permitted  Levels  (MPLs)  of  use  currently  authorised in  Annex  II  of 
Regulation (EC) No 1333/2008. 
Overall, exposure estimates for Sunset Yellow FCF (E 110) based on the currently authorised MPLs of 
use in foods are well below the new ADI of 4 mg/kg bw/day established by the ANS Panel, for all 
population  groups.  This  is  due  both  to  the  fact  that  MPLs  for  Sunset  Yellow  FCF  were  largely 
decreased,  following  the  amendment  of  the  legislation  in  2013,  and  to  a  more  refined  exposure 
assessment  being  performed,  taking  into  account  the  restrictions/exceptions  listed  in  Annex  II  of 
Regulation (EC) No 1333/2008 and the use of the EFSA Comprehensive Database (FoodEx) system. 
It  should  be  noted  that  in  2012,  further  to  the  amendment  of  Annex  II  of  Regulation  (EC)  No 
1333/2008 as regards the conditions of use and the use levels for Sunset Yellow FCF (E 110) ,  MPLs 
were either  withdrawn or  decreased by a factor of 2 to 30. Updated information on the actual use 
levels  of  Sunset  Yellow  FCF  in  foods  was  made  available  by  the  industry  for  few  of  the  food 
categories in which this food additive is authorised. In addition, concentration data on Sunset Yellow Reconsideration of the temporary ADI and 
refined exposure assessment for Sunset Yellow FCF (E 110) 
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FCF in foods were provided by Member States. These data were in their majority collected before 
June 2013. Nevertheless, in the absence of more recent data, these data were also considered for the 
refined exposure assessment scenario, provided that the values were below the currently authorised 
MPLs of use of Sunset Yellow FCF. 
The Panel noted that the results of the present exposure estimates for Sunset Yellow FCF based both 
on the currently authorised MPLs and reported use levels are well below the new ADI of 4 mg/kg 
bw/day for all population groups. The exposure results are much lower compared to the ones from the 
exposure assessment performed by the ANS Panel in 2009 (EFSA ANS Panel, 2009) for all population 
groups. For children and toddlers, the present results are of the same magnitude when compared with 
the exposure estimates obtained in the refined exposure assessment of Sunset Yellow FCF (E 110) 
performed by EFSA in 2011. 
Overall, the Panel concluded that using data provided by the food industry and Member states, the 
reported uses and use levels of Sunset Yellow FCF (E 110) would not be of safety concern. Reconsideration of the temporary ADI and 
refined exposure assessment for Sunset Yellow FCF (E 110) 
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
The  European  Food  Safety  Authority  (EFSA)  has  re-evaluated  the  safety  of  Sunset  Yellow  FCF 
(E 110) as a food additive in 2009 (EFSA ANS Panel, 2009). 
EFSA decided to reduce the ADI, by an extra uncertainty factor of 2.5, to 1 mg/kg bw/day and to 
make the ADI temporary for 2 years. Furthermore, it was stressed that within that period, clarification 
of the effects of Sunset Yellow FCF on the testis, sperm morphology and sperm mobility should be 
provided, based on a 28-day study performed according to the updated OECD test guideline 407. 
The  study  in  question  has  now  been  submitted  by  the  International  Association  of  Color 
Manufacturers. 
The European Commission asks EFSA to evaluate this new information and possibly reconsider the 
temporary ADI established for Sunset Yellow FCF. 
The above request for evaluation of new toxicological data on Sunset Yellow FCF (E 110) has been 
combined with a previous request to EFSA to provide a refined exposure assessment for twelve food 
colours, including Sunset Yellow FCF, which were already re-evaluated by the ANS Panel and for 
which a possible exceedance of the ADI was shown. 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
In accordance with Article 29 (1) (a) of Regulation (EC) No 178/2002, the European Commission asks 
the European Food Safety Authority to provide a scientific opinion as regards the clarification of the 
effects of Sunset Yellow FCF on the testis, sperm morphology and sperm mobility and to reconsider 
the temporary ADI based on this clarification. 
In addition, the European Food Safety Authority is to provide a refined exposure assessment for 
Sunset  Yellow  FCF  (E 110)  taking  into  account  the  restrictions/exceptions  listed  in  Annex  II  of 
Regulation (EC) No 1333/2008, especially in the case of main contributors. In order to provide a 
refined exposure assessment, EFSA is requested to use the EFSA Comprehensive Food Consumption 
Database (FoodEx) system, excluding the non-relevant food subgroups from the intake calculations. 
INTERPRETATION OF TERMS OF REFERENCE 
The ANS Panel noted that since the publication of its scientific opinion on the re-evaluation of Sunset 
Yellow FCF for use as a food additive in 2009, an updated evaluation has been completed by the Joint 
FAO/WHO  Expert  Committee  on  Food  Additives  (JECFA)  in  2011  (JECFA,  2011).  In  its  latest 
evaluation, JECFA concluded that the ADI for Sunset Yellow FCF should be increased from 2.5 
mg/kg bw/day to 4 mg/kg bw/day. Thus, the ANS Panel considered that, in order to fulfil the current 
mandate, the latest evaluation performed by JECFA in 2011 should also be taken into account for 
setting an ADI for this food colour, alongside any other relevant publications that might have become 
available since the publication of the previous scientific opinion. Reconsideration of the temporary ADI and 
refined exposure assessment for Sunset Yellow FCF (E 110) 
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EVALUATION 
1.  Introduction 
Sunset Yellow FCF (E 110)
4 is an azo dye authorised as a food additive in the EU and previously 
evaluated by JECFA  (JECFA, 1982) and the  Scientific Committee for Food ( SCF) in 1983 (SCF, 
1984). Both committees, at the time, established an ADI of 0-2.5 mg/kg bw/day. 
The EFSA ANS Panel has re-evaluated the safety of Sunset Yellow FCF (E 110) as a food additive in 
2009
 (EFSA ANS Panel, 2009). The Panel decided to reduce the ADI to 1 mg/kg bw/day, by applying 
an extra uncertainty factor of 2.5, and to make the ADI temporary for 2 years. This decision was based 
on the effects observed in the testis of rats in a study where Sunset Yellow of unknown purity, bought 
on the local market in India, was used as the testing material (Mathur, 2005a). The ANS Panel stressed 
that within a period of 2 years, clarification of the effects of Sunset Yellow FCF on the testis, sperm 
morphology and sperm mobility should be provided, based on a 28-day study performed according to 
the updated OECD test guideline 407. In sub-chronic and chronic studies, described in the former 
evaluations by JECFA and the SCF, no effects on testes or other reproductive effects were described. 
For that reason, the ANS Panel in its 2009 opinion decided to ask for a 28-day toxicity study with 
well-defined material.  
Following  a  request  by  the  European  Commission,  asking  EFSA  for  a  reconsideration  of  the 
temporary  ADI  of  Sunset  Yellow  FCF (E 110)  based  on a  newly  submitted 28-day  study  in  rats 
(Products  Safety  Labs,  2012,  unpublished),  the  ANS  Panel  evaluated  the  new  data  provided  and 
reconsidered the temporary ADI of 1.0 mg/kg bw/day established by the ANS Panel in 2009 (EFSA 
ANS Panel, 2009). 
In addition, the ANS Panel noted that in 2011 JECFA withdrew the previously set ADI for Sunset 
Yellow FCF, and established a new ADI of 0-4 mg/kg bw/day (JECFA, 2011). This latest JECFA 
evaluation encompassed previously reviewed data, published information that had become available 
since  Sunset  Yellow  FCF  was  last  considered  by  JECFA,  and  a  comprehensive  review  of  one 
unpublished long-term feeding study in mice and two studies in rats, provided by the United States 
Food and Drug Administration (FDA). 
Additionally, in reconsidering the previously established temporary ADI, the ANS Panel evaluated 
other relevant publications that have become available since the publication of its previous scientific 
opinion and were identified through an ongoing procurement contract for extensive literature searches 
on food additives, previously evaluated by the ANS Panel. 
Furthermore, following the conclusions of the 2009 opinion as regards anticipated dietary exposure to 
Sunset Yellow FCF (E 110), EFSA was requested to carry out a refined exposure assessment for this 
food additive. In that opinion, the ANS Panel had evaluated the exposure to Sunset Yellow FCF 
(E 110) on the basis of the uses and use levels authorised in the legislation and the reported use levels 
as provided by industry, and concluded that at the maximum reported levels of use of Sunset Yellow 
FCF, refined intake estimates were generally below the temporary ADI of 1 mg/kg bw/day. However, 
in 1- to 10-year old children, the mean and the high percentiles of exposure could be higher than this 
temporary ADI, at the upper end of the range. 
The  aim  of  the revised  exposure assessment is  to provide updated  exposure  estimates  for  Sunset 
Yellow  FCF,  from  its  use  as  a  food  colour,  using  the  EFSA  Comprehensive  European  Food 
Consumption Database (Comprehensive Database) and the FoodEx classification system and taking 
into consideration the restrictions/exceptions listed in Annex II of Regulation (EC) No 1333/2008. 
                                                       
4  The food colour Sunset Yellow FCF (E 110), with CAS Registry Number No. 2783-94-0 is also known as FD&C Yellow  
  No. 6 (or FD&C Yellow # 6). In this opinion both terminologies have been used synonymously. Reconsideration of the temporary ADI and 
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Through a call
5 for concentration and usage data on Sunset Yellow FCF (E 110) in foods, launched by 
EFSA in March 2013, new data were made available from Member States (MS) and by the industry. 
2.  Evaluation of new toxicological data 
2.1.  28-day dietary study in male rats 
The ANS Panel was provided with data from a 28-day dietary study in male rats conducted by Product 
Safety Labs (2012, unpublished). 
The study by Product Safety Labs, was performed under Good Laboratory Practice (GLP) and a 
certificate of analysis of the test substance, FD&C Yellow No. 6/Sunset Yellow FCF was included in 
the report. As proposed by the ANS Panel (EFSA ANS Panel, 2009), histopathological examination 
and sperm analysis were performed after dietary exposure of male rats for 28 days following OECD 
test guideline 407 (OECD, 2008).  
Product Safety Labs (2012, unpublished) performed a 28-day dietary study in male Hsd:SD® rats 
(n=10/group)  to  determine  the  potential  of  FD&C  Yellow  No.  6/Sunset  Yellow  FCF  to  produce 
toxicity. Dietary levels of 0 mg/kg, basal diet, 6 000 mg/kg, 12 000 mg/kg, 18 000 mg/kg were tested 
(equivalent to 0, 490, 944 and 1 475 mg/kg bw/day, respectively). The diets were provided ad libitum. 
Homogeneity, stability and concentration of the test diets were verified. The animals were observed 
for signs of toxicity and behavioural changes at least once daily during the study, and weekly for a 
battery of detailed clinical observations. Body weights were recorded prior to test initiation (day 0), 
and approximately weekly thereafter, and just prior to sacrifice. Individual food consumption was also 
recorded  to  coincide  with  body  weight  measurements.  Blood  was  sampled  from  all  animals  for 
haematology  and  clinical  chemistry  analysis  and  prior  to  necropsy  for  coagulation  assessments. 
Necropsies were performed on all animals in the study, and selected organs and tissues from all 
animals were preserved. Microscopic evaluation was performed on organs and tissues of animals of 
the  control  and  the  18 000  mg/kg  groups.  In  addition,  gross  lesions  of  potential  toxicological 
significance, noted at the time of terminal sacrifice, were also examined microscopically. 
There  were  no  mortalities  during  the  study.  In-life  clinical  observations included  orange  scrotum 
staining and orange/red cage staining for all animals of the test dose groups; red nasal discharge for 
one animal in the 6 000 mg/kg group, and soft faeces for one animal each in the 6 000 and 12 000 
mg/kg  groups,  and  6  animals  fed  18 000  mg/kg.  Two  control  animals  exhibited  black/red  nasal 
discharge.  There  were  no  test  substance-related  effects  on  body  weight,  body  weight  gain,  food 
consumption or food efficiency. White blood cell concentration and absolute basophil concentration 
was  decreased  in  males  fed  18 000  mg/kg.  No  statistically  significant  differences  in  coagulation 
parameters were observed. Cholesterol concentration was decreased in males fed 6 000 and 18 000 
mg/kg, albumin was increased in males fed 12 000 mg/kg, inorganic phosphorus was decreased in 
males fed 18 000 mg/kg, sodium concentration was decreased in males fed 18 000 mg/kg. Urine pH 
was decreased in males fed 12 000 and 18 000 mg/kg, urobilogen concentration was increased in 
males fed 12 000 mg/kg.  The authors stated that these findings, which were not accompanied by 
clinical and histopathological changes, were considered non-adverse and toxicologically insignificant. 
Similarly, at scheduled sacrifice, there were no macroscopical or histological findings related to the 
test substance, FD&C Yellow No. 6/Sunset Yellow FCF. At macroscopic examination, for each of the 
control group and the group fed 12 000 mg/kg, one male showed left epididymal cysts, which was 
confirmed microscopically as a sperm granuloma. The statistically significant increases in testes-to-
brain  weight  ratios  observed  in  animals  of  the  groups  fed  12 000  and  18 000  mg/kg  were  not 
accompanied by histopathological findings in the 18 000 mg/kg group. Absolute testes weight and 
testes-to-body weight of these groups were not statistically significantly increased. The sperm analysis 
(sperm  motility,  epididymal  sperm  count,  homogenization  resistant  spermatid  count,  or  sperm 
morphology) showed no dose-related adverse effects. Therefore, the authors concluded that under the 
                                                       
5  Call for food additives usage level and/or concentration data in food and beverages intended for human consumption.  
  Published: 27 March 2013. http://www.efsa.europa.eu/en/data/call/130327.htm  Reconsideration of the temporary ADI and 
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conditions of this study and based on the endpoints evaluated, the No-Adverse-Effect Level (NOAEL) 
of FD&C Yellow No. 6/Sunset Yellow FCF in the diet of male rats is 18 000 mg/kg diet (equivalent to 
1 475 mg/kg bw/day), the highest dose level tested. The Panel agreed with this conclusion.  
2.2.  Latest evaluation by JECFA (2011) 
The ANS Panel noted that in 2011 JECFA withdrew the previously set ADI for Sunset Yellow FCF, 
and established a new ADI of 0-4 mg/kg bw/day (JECFA, 2011). This latest evaluation performed by 
JECFA encompassed previously reviewed data, published information that had become available since 
Sunset  Yellow  FCF  was  last  considered  by  the  Committee  and  a  comprehensive  review  of  one 
unpublished long-term feeding study in mice and two in rats, provided by the United States Food and 
Drug Administration (FDA). Detailed summaries of these studies are also reported in the FDA Final 
Rule on the permanent listing of FD&C Yellow No 6 for use generally in food drugs and cosmetics
6. 
2.2.1.  Summary of the unpublished long-term feeding studies reviewed by FDA and used to 
determine the ADI of 4 mg/kg bw/day by JECFA 
The full study reports for the long-term feeding studies (one in mice and two studies in rats which 
were mentioned in the 2011 JECFA evaluation) were made available to the ANS Panel. 
Mice 
The final study report, dated 31 December 1982, and obtained from FDA, refers to Project No. 77-
1779 “A long-term oral carcinogenicity study of FD&C Yellow #6 in mice” by Bio/dynamics Inc. The 
abstract  states  the  following:  “This  study,  conducted  for  the  Certified  Color  Manufacturers 
Association (CCMA) was designed to evaluate the carcinogenicity of FD&C Yellow #6 and to meet 
requirements established by the U.S. FDA, Bureau of Foods, for long-term feeding studies in mice”.  
FD&C Yellow No. 6 was administered continuously in the diet to 600 Charles River CD-1 mice 
(60/sex/group)  at  dose  levels  of  0 %  (control  IA),  0 %  (control  IB),  0.5 %,  1.5 %  and  5.0 %  for 
approximately  20  and  23  months  (males  and  females,  respectively).  Ten  animals/sex/group  were 
randomly selected for haematology evaluations at 3, 6, 12 and 18 months. All surviving males were 
sacrificed in Month 20 and all surviving females in Month 23. 
Mortality was comparable for the control and high-dose females, although mortality occurred earlier in 
the high-dose females, i.e. 50 % mortality occurred in Month 17 for the high-dose females versus 
Month 18 or 19 for the control females. In males, mortality was higher in the high-dose group (p < 
0.01) and occurred earlier, i.e. 50 % mortality occurred in Month 16 for the high-dose males versus 
Month 18 or 19 for the control males. Mean body weights for the high-dose males and females were 
consistently lower than those of the controls throughout the study. Differences from controls at the end 
of  the  study  were  -10 %  and  -9 %  for  the  high-dose  males  and  females,  respectively.  Food 
consumption was consistently increased for the mid- and high-dose males relative to controls, while 
values for the low-dose males were only slightly increased. No treatment-related effect was apparent 
on mortality or body weight data for the low- and mid-dose animals, food consumption of treated 
females, or haematologic parameters for all treated groups. Following the first year of the study, an 
increased incidence of ocular opacities was noted in the high-dose females. At the same time in the 
study, in males, the incidence was highest in one of the control groups. As the incidence in the high-
dose  females  and  control  males  was  comparable,  this  observation  was  considered  of  equivocal 
significance by the authors of the study. The Panel agreed with this conclusion. After the first year, an 
increased incidence of abdominal distension was observed in all groups, including controls. Complete 
histopathological examination of all preserved organs and tissues (including reproductive organs), 
tissues masses and other gross changes was done. The evaluation of these tissues revealed a variety of 
neoplastic and non-neoplastic changes. These histopathological changes were considered unrelated to 
the dietary administration of FD&C Yellow No. 6. Statistical analysis of neoplasm data indicated no 
                                                       
6  Federal Register, Volume 51, No 223, November 19, 1986. P. 41765-41783. 21 CFR Parts 74, 81, 82, and 201 [Docket No  
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increase  in  the  incidence,  nor  decreased  time  to  onset  in  the  treated  groups.  The  gross  and 
microscopical examination revealed no adverse histopathological changes that could be attributed to 
treatment with FD&C Yellow No. 6.  
Rats 
Two long-term feeding studies with in utero exposure to FD&C Yellow No. 6 were carried out in 
Charles River Albino (CD)® rats. 
The final study report, dated 31 December 1982, and obtained from FDA, refers to Project No. 77-
1778 “A long-term oral carcinogenicity study of FD&C Yellow #6 in rats” by Bio/dynamics Inc. The 
abstract  states  the  following:  “This  study,  conducted  for  the  Certified  Color  Manufacturers 
Association (CCMA) was designed to evaluate the toxicity and carcinogenicity of FD&C Yellow #6 
and to meet requirements established by the U.S. FDA, Bureau of Foods, for long-term feeding studies 
with exposure beginning in utero”.  
FD&C Yellow No. 6 was administered continuously in the diet to 600 Charles River Albino rats 
(60/sex/group) at dose levels of 0 % (control IA), 0 % (control IB), 0.75 %, 1.5 % and 3.0 % for 
approximately  two  months  prior  to  mating.  Following  the  reproductive  phase,  a  maximum  of 
2 animals/sex/litter within each group, were randomly selected to populate the long-term segment (F1) 
of the study. Dietary administration continued at the same dose levels for 700 rats (70/sex/group) for a 
period  of  approximately  30  months  for  the  males  and  29  months  for  the  females.  Ten 
animals/sex/group were randomly selected for clinical laboratory examinations at 3, 6, 12, 18 and 24 
months. Ophthalmoscopic examinations were performed on all animals following receipt (F0), after 
selection for the long-term segment and at the 3, 6, 12, 18 and 24 months interval (F1). An interim 
necropsy of 10 rats/sex/group was performed at 12 months. All surviving  male animals (9) were 
sacrificed in Month 30 and the surviving females (9) in Month 29. 
During  the  F0  generation  (premating  period),  no  treatment-related  effect  on  mortality  was  noted. 
However, body weights were lower and food consumption was increased in a dose-related manner in 
the mid- and high-dose males. Mean pup weight at birth was greater in the high-dose group than in 
controls. However, pup survival was reduced early during lactation and pup weight gain was reduced 
throughout lactation, which resulted in the lowest pup weight of this group at day 21 of lactation. 
Mean pup weight was also reduced for the mid-dose group at the end of lactation. No other effects on 
reproduction parameters were noted. During the F1 generation, mortality was higher in the high-dose 
females than in controls. However, the difference from controls was not statistically significant. Body 
weights for the mid- and high-dose males and females were lower than controls at the initiation of the 
F1 part of the study. Thereafter, body weights for all treated groups were generally comparable to, or 
greater than controls throughout most of the study, with the exception that at the end of the study body 
weights of the mid-dose males and high-dose animals of both sexes were lower than that of controls (< 
-10 %). Food consumption was increased for all treated females and males during the first month 
(males) and first three months (females) of the F1 generation. Thereafter, increased food consumption 
was noted in the high-dose males and females, and sporadically in the mid-dose females. Higher blood 
urea nitrogen concentrations were noted in the high-dose females in months 18 and 24: differences 
from  controls  were  statistically  significant.  Slight  elevations  in  serum  glutamic  oxaloacetic 
transaminases  noted  in  the  mid-  and  high-dose  males  in  months  18  and  24  were  considered  of 
equivocal toxicological significance. 
At sacrifice after 12 months, organ weight data for the treated animals were comparable to those for 
controls. At the terminal sacrifice, the mean body weight of the high-dose females was markedly 
lower than that of controls, while the absolute and relative (to body weight) weights of the kidneys 
were elevated (the latter being statistically significant). The absolute and relative kidney weights for 
the  low-  and  mid-dose  females  and  mid-  and  high-dose  males  were  also  slightly  elevated.  No 
treatment-related  effects  were  apparent  from  general  physical  observations,  ophthalmology  or 
haematology  data.  Macroscopical  examination  revealed  yellow  to  orange  discolouration  of  the Reconsideration of the temporary ADI and 
refined exposure assessment for Sunset Yellow FCF (E 110) 
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gastrointestinal tract in animals of the treated groups. An increased incidence of adrenal masses was 
noted in the low- and high-dose males. Histopathological examination of tissues from all control and 
high-dose rats revealed no carcinogenic effect in male rats that could be attributed to treatment with 
FD&C Yellow No. 6. In females of the high-dose group, an increased incidence of adrenal medullary 
tumours (phaeochromocytomas) was observed. The increase was statistically significant by the Fischer 
Exact test. The FDA scientists have concluded, and the Panel agreed with that conclusion, that the 
higher incidence of rats with phaeochromocytomas in the high-dose female group is not related to 
treatment with FD&C Yellow No. 6 for the following reasons: 1. the small increase in the number of 
treated animals with a type of tumour of a spontaneous high and variable incidence; 2. the lack of any 
effect on the latency period; 3. the absence of a dose-response relationship between the incidence and 
severity of the medullary lesions (phaeochromocytomas and hyperplasias); 4. the lack of a treatment-
related effect on medullary adrenal lesions in male rats; 5. the lack of similar effects in male or female 
rats in any of the other rat studies conducted with FD&C Yellow No. 6.  
The other final study report, dated 31 December 1982, and obtained from FDA, refers to Project No. 
78-2211  “A  long-term  oral  toxicity/carcinogenicity  study  of  5.0 %  FD&C  Yellow  #6  in  rats”  by 
Bio/dynamics Inc. The abstract states the following: “This study, conducted for the Certified Color 
Manufacturers  Association  (CCMA)  was  designed  to  evaluate  the  potential  toxicity  and 
carcinogenicity of FD&C Yellow #6 and to meet requirements established by the U.S. FDA, Bureau of 
Foods, for long-term feeding studies with exposure beginning in utero”.  
FD&C Yellow No. 6 was administered continuously in the diet to 240 Charles River Albino rats 
(60/sex/group)  at  dose  levels of  0.0 %  and  5.0 %  for  approximately  two  months  prior  to  mating. 
Following  the  reproductive  phase,  a  maximum  of  2  animals/sex/litter  within  each  group  were 
randomly  selected  to  populate  the  long-term  segment  (F1)  of  the  study.  Dietary  administration 
continued at the same dose levels for 280 rats (70/sex/group) for a period of approximately 26 and 28 
months,  for  males  and  females  respectively.  Ten  animals/sex/group  were  randomly  selected  for 
clinical laboratory analyses at 3, 6, 12, 18 and 24 months (F1). Ophthalmoscopic examinations were 
performed on all animals following receipt (F0), after selection for the long-term segment and at the 3, 
6, 12, 18 and 24 months interval (F1). An interim necropsy of 10/sex/group was performed at 12 
months. The study was terminated in Month 26 and Month 28, for male and female rats, respectively.  
During  the  F0  generation  (premating  period),  no  treatment-related  effect  on  mortality  was  noted. 
However,  body  weights  of  the  treated  males  were  lower  than  those  of  controls,  while  food 
consumption was increased for the treated males and females. Pup survival was reduced for the treated 
group during days 0-14 of lactation and during the post-weaning period, while mean pup weight was 
lower than that of controls at day 21 of lactation. No other effects on reproduction parameters were 
noted. During the F1 generation, mortality of the treated males and females was slightly higher than 
that  of  controls;  differences  from  controls  were  statistically  significant  for  the  males  only.  Body 
weights of the treated males and females were lower than that of controls at the initiation of the F1 part 
of the study and remained lower throughout the remainder of the study. Differences from controls 
were generally statistically significant for the males, but less frequently for the females. At the end of 
the study, differences from control weights were -15 % and -17 % for the treated males and females, 
respectively.  Food  consumption  was  statistically  significantly  increased  for  the  treated  animals 
throughout  the  study.  Slight  to  statistically  significant  decrease  in  the  mean  haemoglobin 
concentration, haematocrit and erythrocyte counts were noted in the treated animals at Months 3 and 
6. However, as values for these parameters were comparable to or higher than those of controls at 
subsequent intervals, these difference were not considered to be of toxicological significance.  
At sacrifice after 12 months, slight but not statistically significant increases in the mean absolute and 
relative (to body weight) kidney weights were noted in the treated females. At the terminal sacrifice, 
the absolute and relative weights of the thyroids were elevated in the treated males and females. In the 
females,  the  absolute  and  relative  kidney  weight  was  slightly,  but  not  statistically  significantly 
increased. Slight increases in relative liver and testes weights were also noted in the treated animals. 
No treatment-related effects were apparent from general physical observation or ophthalmology data. Reconsideration of the temporary ADI and 
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Macroscopical  examination  revealed  yellow/orange  intestinal  discolouration  and  splenic 
nodules/mass(es) in treated male animals. Histopathological evaluation of all tissues of the controls 
and treatment group revealed an increased incidence of renal tubular cell adenomas in females (5/70 
versus 0/70 in the control group). Other tissue alterations noted occurred with comparable incidence in 
control and treated animals, and were not considered related to the administration of FD&C Yellow 
No. 6.  
An ad hoc Panel of Experts constituted a National Toxicology Program (NTP) Peer Review Panel 
which reviewed the slides of the kidney lesions from the female rats of the 5 % FD&C Yellow No. 6 
group and their controls. The NTP Peer Review Panel concluded that “the weight of evidence of all the 
studies does not suggest that FD&C Yellow No. 6 is a renal carcinogen”. The main reasons that led 
the NTP Peer Review Panel to this conclusion are: 1. the acknowledged debatable nature of the small 
renal  proliferative  lesions  variously  categorised  by  different  pathologists  as  representing  nodular 
hyperplasia, adenomatous hyperplasia or benign renal tubular adenomas; 2. the lack of concurrence as 
to  whether  lesions  were  hyperplastic  or  benign;  3.  the  absence  of  any  definitive  malignant  renal 
cortical tubular neoplasms in the treated rats; 4. the absence of any type of renal tubular proliferative 
response  in  the  male  rats  (generally  regarded  as  more  sensitive  than  female  rats  to  experimental 
tubular neoplasias) used in this study; 5. the negative genetic toxicology database; 6. the previously 
reported chronic studies which were all negative for carcinogenicity; and 8. the judgement that the 
dose chosen was a good approximation of the maximum tolerated dose (MTD). 
Based on these considerations and conclusions of the ad hoc NTP Peer Review Panel of Experts, the 
FDA concluded that FD&C Yellow No. 6 when fed in the diet of laboratory animals does not induce 
carcinogenic activity in the kidneys or any other site. The ANS Panel agreed with this conclusion. 
Furthermore, the ANS Panel agreed with the conclusion in the FDA Final Rule on the permanent 
listing of FD&C Yellow No. 6 for use generally in food drugs and cosmetics,  that based on the 
occurrence of the adverse effect on pup body weight gain observed in rats during the last part of 
lactation in the group fed 1.5 % FD&C Yellow No. 6 in the diet, the NOAEL of this study is 0.75 % 
(equivalent to 375 mg/kg bw/day). 
2.2.2.  Additional toxicological data published after the 2009 ANS Panel opinion 
An extensive literature search was performed on three electronic databases (PubMed, Web of Science, 
Toxnet) covering the time period between approximately one year before the adoption of the opinion 
(i.e. 1 November 2008 until 31 December 2013), aiming to retrieve any relevant toxicological data that 
should be taken into account in the current opinion. Details of the search strings used are shown in 
Appendix 1. 
The safety of Sunset Yellow FCF, with particular respect to the data on its metabolism, genotoxicity 
and  carcinogenicity,  had  already  been  reviewed  by  the  ANS  Panel  in  the  context  of  the  recent 
assessment of Allura Red AC and other structurally related sulphonated mono azo dyes (EFSA ANS 
Panel, 2013). The following additional publications were retrieved in the updated literature search. 
2.2.2.1.  In vivo studies 
No  new  studies  on  ADME,  repeat-dose  toxicity  or  reproductive  and  developmental  toxicity  were 
identified following the aforementioned updated literature search. 
Genotoxicity 
An updated literature search covering genotoxicity studies had already been conducted in the context 
of the recent assessment of Allura Red AC and other structurally related sulphonated mono azo dyes 
(EFSA ANS Panel, 2013). The additional extensive literature search did not reveal any new data in 
addition to those already considered in the statement on Allura Red AC and other structurally related 
sulphonated mono azo dyes (EFSA ANS Panel, 2013). Reconsideration of the temporary ADI and 
refined exposure assessment for Sunset Yellow FCF (E 110) 
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Immunotoxicity 
A study was carried out to investigate the effect of oral administration of Amaranth, Sunset Yellow 
and Curcumin on immunological responses (Hashem et al., 2010). The food colours were administered 
daily by gavage to female Sprague Dawley albino rats (n=10) for 4 weeks: Sunset Yellow FCF was 
administered at a dose of 315 mg/kg bw/day. After the two weeks of treatment all the animals were 
immunostimulated  by  i.p.  injection  of  10  %  sheep  RBC  suspension  (1  ml/rat).  A  group  of  non-
sensitized  rats  was  used  as  the  control.  Body  weight,  relative  body  weight,  total  and  differential 
leukocytes count, mononuclear cell count, delayed hypersensitivity, total protein and serum fractions, 
were determined. Results revealed that oral administration of Sunset Yellow did not affect the body 
weight gain or the spleen weight. On the other hand, Sunset Yellow significantly decreased the weight 
of thymus gland of the rats. Total leukocyte count was not affected. Moreover, oral administration of 
Sunset Yellow revealed a significant decrease in circulating mononuclear cells in peripheral blood. 
Sunset Yellow significantly decreased the delayed hypersensitivity. Total serum protein, albumin, total 
globulin and albumin/globulin (A/G) ratio were not affected by administration of the colouring agent. 
The authors concluded that Sunset Yellow used at dose of 315 mg/kg bw/day exerted a depressing 
effect  on  the  cellular,  but  not  humoral,  immune  response.  The  Panel  noted  that  this  study  was 
conducted with locally sourced uncharacterised material of unknown purity and therefore was not 
considered suitable for risk assessment. 
Neurodevelopmental toxicity and neurobehavioural studies 
Some studies by the same research group aimed at investigating neurodevelopmental toxicity and 
conducted with mixtures of food additives, locally sourced and of unknown purity, were retrieved 
(Ceyhan et al., 2013; Doguc et al., 2013a, 2013b).  
In the study by Ceyhan et al. (2013), a mixture of authorised food colours (Sunset Yellow FCF, 2.5 
mg/kg bw, Allura Red, 7 mg/kg bw/day, Erythrosin, 0.1 mg/kg bw/day, Ponceau 4R, 4 mg/kg bw/day, 
Tartrazine,  7.5  mg/kg  bw/day,  Amaranth,  0.5  mg/kg  bw/day,  Brilliant  Blue  12.5  mg/kg  bw/day, 
Azorubine, 4 mg/kg bw/day and Indigotine 5 mg/kg bw/day, purity of the test material not known) 
was administered to female rats one week before mating, during mating and during the gestation 
period at doses corresponding to the respective ADIs. The effects of intrauterine exposure of synthetic 
food  colours  on  expression  of  N-methyl-D-aspartate  receptors  (NMDARs)  subunits  (NR2A  and 
NR2B) and nicotinic acetylcholine receptors (nAChRs) subunits α7, α4, ß2 were investigated in their 
offspring when they became adults. The results indicated that exposure to the mixture of food colours 
during the fetal period may lead to alterations in expressions of NMDARs and nAChRs in adulthood, 
and the alterations were totally different between males and females. Exposure to the mixture of food 
colours in male rats led to an increase in expression of NR2B and AChR b2 receptor subunits and a 
decrease in nAChR a4 subunits. On the other hand, the main effect of food colours administered to 
female rats was a significant reduction in NR2B expression.  
Two other publications by the same research group (Doguc et al., 2013a, 2013b) investigated the 
effects of the same mixture of authorised food colours (Sunset Yellow FCF, Allura Red, Erythrosine, 
Ponceau  4R,  Tartrazine,  Amaranth,  Brilliant  Blue,  Azorubine  and  Indigotine,  purity  of  the  test 
material not known) administered to female rats before and during gestation at doses corresponding to 
the respective ADIs (in the case of Sunset Yellow FCF 2.5 mg/kg bw/day) on spatial working memory 
and behaviour in their offspring, as measured by Morris water maze and by open-field test and forced 
swim  test,  respectively.  No  adverse  effects  on  spatial  working  memory  and  on  behaviour  were 
observed in offspring, but some parameters of locomotor activity were found to be increased. 
The Panel noted that these studies were conducted with locally sourced uncharacterised material of 
unknown purity and therefore were not considered suitable for risk assessment. Reconsideration of the temporary ADI and 
refined exposure assessment for Sunset Yellow FCF (E 110) 
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2.2.2.2.  In vitro studies 
Neurotoxicity 
In the study by Park et al. (2009), the effects of the food colours Sunset Yellow FCF (obtained from 
Sigma Chemical Co. (St. Louis, MO)), Allura Red, Tartrazine, Amaranth and Brilliant Blue alone and 
in  combination  were  tested  on  both  multipotent,  immortalized  C17.2  cells  as  a  model  for 
developmental  effects,  and  adult  neural  stem  cells  in  the  hippocampus  as  a  model  for  adult 
hippocampal neurogenesis. No significant effects were observed for Sunset Yellow FCF. 
Immunotoxicity 
The  immunotoxic  properties  of  Sunset  Yellow  FCF  have  been  investigated  in  isolated  mice 
splenocytes (Yadav et al., 2013). Sunset Yellow (purity not stated, from Sarabhai Chemicals, Mumbai) 
did not exhibit cytotoxicity up to 250 μg/ml after 72 hours of treatment (cytotoxicity measured as PI 
staining and MTT assay). This dose was therefore chosen for further studies on functional responses of 
T-cells and B-cells. The results showed that Sunset Yellow FCF at the non-cytotoxic dose of 250 
μg/ml significantly suppressed the mitogen-induced proliferation of splenocytes and MLR response. 
Further immunophenotypic analysis revealed that Sunset Yellow FCF alters the relative expression of 
CD3e/CD4/CD8 in T cells and CD19 in B-cells. Consistent with the suppression of T-cell and B-cell 
responses and altered surface receptor expression, Sunset Yellow FCF also lowered the expression of 
IL2, IL4, IL6, IL-17, IFN- and TNF- cytokines. 
Oestrogenic activity 
A  reporter  gene  assay  in  the  human  breast  cancer  cell  line  MCF-7  transiently  transfected  with 
luciferase reporter gene construct under control of a concatemer of 3 oestrogen response elements and 
a thymidine kinase promoter was used by Axon et al. (2012) to screen for chemical compounds which 
have the potential to modulate human oestrogen receptor (ER) transcriptional activity. Amongst the 
chemicals tested in this assay was the food colour Sunset Yellow FCF, which showed xenoestrogenic 
activity  with  EC50  %  at  concentration  of  220  nM.  In  addition,  Sunset  Yellow  FCF  treatment 
significantly induced the expression of trefoil factor 1 (TFF1) mRNA as determined by quantitative 
RT-PCR. TFF1 has been previously shown to be an ER-inducible gene in MCF-7 cells (May and 
Westley, 1988) 
The Panel noted however, that the test method used in the study, although widely used in the scientific 
community,  is  not  an  OECD  validated  method,  in  contrast  to  the  BG1Luc  oestrogen  receptor 
transcriptional activation (TA) test method for identifying ER agonists and antagonists (OECD TG 
457 or OECD TG 455).  
2.2.2.3.  Human data 
A case-report of allergic contact dermatitis was reported in one patient after application on the skin of 
an antiseptic solution containing Sunset Yellow FCF (Mc Cleskey, 2011). The Panel noted that the 
route of exposure in this single case-report was not relevant for the assessment of Sunset Yellow FCF 
as a food additive and that the relevance of dermal sensitization reactions for oral sensitization has not 
been established. Reconsideration of the temporary ADI and 
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3.  Exposure assessment of Sunset Yellow (E 110) 
3.1.  Previous exposure assessment of Sunset Yellow FCF (E 110) 
In its 2009 opinion, the ANS Panel had evaluated the exposure to Sunset Yellow FCF (E 110) on the 
basis of the uses and use levels authorised in the legislation
7 and the reported use levels, as identified 
by the Panel from the data made available by industry and other relevant stakeholders.  
Refined exposure estimates had been performed both for children and the adult population according 
to the Tier 2 and Tier 3 approaches described in the SCOOP Task 4.2, whic h combines, respectively, 
detailed individual food consumption information from the population with the Maximum Permitted 
Levels (MPLs) of use, as specified in the Directive 94/36/EC on food colours (Tier 2), and with the 
maximum reported use levels of Sunset Yellow FCF, as identified by the Panel from the data  made 
available (Tier 3). Data for some of the authorised uses of Sunset Yellow FCF had been provided by 
the Confederation of the Food and Drink Industries of the EU (CIAA , now FoodDrinkEurope), the 
Union of European Beverages Associations  (UNESDA), the European Spirits Organisation  (CEPS) 
and the Federation of European Food Additives, Food Enzymes and Food Culture Industries (ELC). 
Additional data had been made available by the UK Food Standards Agenc y (FSA), the Food Safety 
Authority of Ireland (FSAI) and the Agence Française de Sécurité Sanitaire  des Aliments (AFSSA, 
now ANSES). 
The Panel concluded that at the maximum reported levels of use of Sunset Yellow FCF, refined intake 
estimates were generally below the temporary ADI of 1 mg/kg bw/day, although in 1 - to10-year old 
children the mean and the high percentiles of exposure (95
th/97.5
th) could be higher than this ADI, at 
the upper end of the range (Table 1). The main contributors to the total anticipated exposure (>10 % in 
all countries) were soft drinks, desserts, including flavoured milk products, sauces, seasonings (e.g. 
curry powder, tandoori), pickles, relishes, chutney, piccalilli and fine bakery wares. 
Table 1:   Summary of anticipated exposure to Sunset Yellow FCF (E 110) in children and the adult 
population (mg/kg bw/day) (EFSA ANS Panel, 2009) 
 
Adult UK 
population
(a) 
(> 18 years 
old) 
Pre-school UK 
children
(a) 
(1.5-4.5 years old, 
15 kg body weight) 
Children 
EXPOCHI population
(b) 
(1-10 years old, 
25-30 kg body weight) 
Maximum permitted levels 
 Mean exposure 
 Exposure 95
th or 97.5
th percentile
(a) 
 
0.5 
1.1 
 
1.4 
3.5 
 
0.3 – 2.5 
0.7 – 6.7 
Maximum reported use levels  
 Mean exposure 
 Exposure 95
th or 97.5
th percentile
(a) 
 
0.3 
0.9 
 
1.1 
3.2 
 
0.2 – 2.1 
0.6 – 5.8 
(a): For UK, estimates are based on the UNESDA report which gives the 97.5
th percentile intake from beverages plus per 
capita average from the rest of diet (Tennant, 2006). 
(b): For EU children, estimates are based on the EXPOCHI report, which gives the 95
th percentile intake. 
In 2011, EFSA carried out a revised exposure assessment of Sunset Yellow FCF (E 110) from its use 
as a food additive, in children, based on the revised proposed use levels as requested by the European 
Commission  (EFSA,  2011a).  The  revised  use  levels  proposed  were  lower  for  all  food  categories 
compared to those considered in the former EFSA evaluation (EFSA ANS Panel, 2009), and 18 food 
uses previously permitted, were withdrawn Four different scenarios had been considered, differing 
only in the MPLs proposed for the use of Sunset Yellow FCF in flavoured drinks: 10, 15, 18 and 20 
mg/l respectively. Revised exposure estimates have been calculated for Tier 2 applying the same 
                                                       
7  European  Parliament  and  Council  Directive  94/36/EC  of  30  June  1994  on  colours  for  use  in  foodstuffs.  OJ  L  237, 
10.9.1994, p. 13. Reconsideration of the temporary ADI and 
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methodology used by the ANS Panel for the re-evaluation of food colours, based on the proposed 
revised use levels, combined with food consumption data for children. 
The mean anticipated dietary exposure to Sunset Yellow FCF in European children (aged 1-14 years) 
ranged  from  0.02  to  0.4  mg/kg  bw/day,  and  the  high  level  estimates  ranged  from  0.08  to  1.2 
mg/kg bw/day. The main contributors (>10 % in all countries) to the total anticipated exposure to 
Sunset Yellow FCF of European children were non-alcoholic flavoured drinks and desserts, including 
flavoured milk products. It was concluded that, for all scenarios, the high level exposure estimates for 
children calculated on the basis of the proposed revised MPLs, were below the temporary ADI of 1 
mg/kg bw/day for all European countries considered (maximum of 0.8 mg/kg bw/day), except for UK 
pre-school children, who might slightly exceed the ADI in scenarios 3 and 4 (1.1 and 1.2 mg/kg 
bw/day, respectively). 
3.2.  Maximum Permitted Levels of use of Sunset Yellow FCF (E 110) 
Maximum Permitted Levels (MPLs) of use for Sunset Yellow (E 110) have been defined in Annex II 
of Regulation (EC) No 1333/2008
8 of the European Parliament and of the Council Commission on 
food additives. 
Currently Sunset Yellow FCF (E 110) is a food colour authorised in the EU with MPLs ranging from 5 
to 200 mg/kg in foods (Table 2). 
Table 2 summarises foods that are permitted to contain Sunset Yellow and the corresponding MPLs as 
set by Annex II of Regulation (EC) No 1333/2008. 
Table 2:   MPLs of Sunset Yellow (E 110) in foods according to the Annex II of Regulation 
(EC) No 1333/2008 
FCS 
Category 
No 
Food categories  Restrictions/exception 
Current 
MPL 
(mg/l or 
mg/kg as 
appropriate) 
Previous 
MPL 
(mg/l or 
mg/kg as 
appropriate) 
1.4 
Flavoured fermented milk 
products including heat treated 
products 
  5 
(a)  150 
1.6.3  Other creams  only flavoured creams  5 
(a)  150 
4.2.4.1  Fruit and vegetable preparations 
excluding compote 
only mostarda di frutta  35 
(a)  200 
5.2  Other confectionery including 
breath freshening microsweets 
except candied fruit and 
vegetables; traditional sugar 
coated nut- or cocoa-based 
confectionery of almond 
shape or host shape, typically 
longer than 2 cm and 
typically consumed at 
celebratory occasions, i.e. 
weddings, communion, etc. 
35 
(a)  300 
5.2  Other confectionery including 
breath freshening microsweets 
only candied fruit and 
vegetables  10 
(a)  200 
5.2  Other confectionery including 
breath freshening microsweets 
only traditional sugar coated 
nut- or cocoa-based 
confectionery of almond 
shape or host shape, typically 
longer than 2 cm and 
typically consumed at 
50 
(a)  N/A 
                                                       
8  Regulation (EC) No 1333/2008 of the European Parliament and of the Council on food additives. OJ L 354, 31.12.2008, p. 
16. Reconsideration of the temporary ADI and 
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FCS 
Category 
No 
Food categories  Restrictions/exception 
Current 
MPL 
(mg/l or 
mg/kg as 
appropriate) 
Previous 
MPL 
(mg/l or 
mg/kg as 
appropriate) 
celebratory occasions, i.e. 
weddings, communion, etc. 
5.3  Chewing gum    10 
(a)  300 
5.4 
Decorations, coatings and fillings, 
except fruit based fillings covered 
by category 4.2.4 
only decorations, coatings 
and sauces, except fillings  35 
(a)  500 
5.4 
Decorations, coatings and fillings, 
except fruit based fillings covered 
by category 4.2.4 
only fillings  35 
(a)  300 
6.6  Batters    35 
(a)  500 
8.2.1  Non-heat-treated processed meat  only sobrasada  15  135 
8.2.3  Casings and coatings and 
decorations for meat  
only decorations and coatings 
except edible external 
coating of pasturmas 
35 
(a)  500 
9.2. 
Processed fish and fishery 
products including molluscs and 
crustaceans 
only in salmon substitutes 
based on Theragra 
chalcogramma and 
Pollachius virens 
200 
(b)  N/A 
9.3  Fish roe 
except Sturgeons' eggs 
(Caviar)  200 
(a)  300 
12.4  Mustard    50 
(a)  300 
12.6  Sauces  only in pickles and piccalilli  30 
(c)  N/A 
12.9  Protein products, excluding 
products covered in category 1.8 
only meat and fish analogues 
based on vegetable proteins  20 
(a)  100 
13.2 
Dietary foods for special medical 
purposes defined in Directive 
1999/21/EC (excluding products 
from food category 13.1.5) 
  10 
(a)  50 
13.3 
Dietary foods for weight control 
diets intended to replace total 
daily food intake or an individual 
meal (the whole or part of the 
total daily diet) 
  10 
(a)  50 
14.1.4  Flavoured drinks 
excluding chocolate milk and 
malt products  20 
(a)  100 
14.2.3  Cider and perry  excluding cidre bouché  10 
(c)  200 
14.2.4  Fruit wine and made wine    10 
(a)  200 
14.2.6  Spirit drinks as defined in 
Regulation (EC) No 110/2008 
except: spirit drinks as 
defined in Article 5(1) and 
sales denominations listed in 
Annex II, paragraphs 1-14 of 
Regulation (EC) No 
110/2008 and spirits 
(preceded by the name of the 
fruit) obtained by maceration 
and distillation, Geist (with 
the name of the fruit or the 
raw material used), London 
Gin, Sambuca, Maraschino, 
Marrasquino or Maraskino 
and Mistrà 
100 
(a)  200 
14.2.7.1  Aromatised wines  except americano, bitter vino  50 
(a)  200 
14.2.7.1  Aromatised wines  only bitter vino  50 
(d)  100 
14.2.7.2  Aromatised wine-based drinks 
except bitter soda, sangria, 
claria, zurra  50 
(a)  200 
14.2.7.2  Aromatised wine-based drinks  only bitter soda  50 
(e)  100 Reconsideration of the temporary ADI and 
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FCS 
Category 
No 
Food categories  Restrictions/exception 
Current 
MPL 
(mg/l or 
mg/kg as 
appropriate) 
Previous 
MPL 
(mg/l or 
mg/kg as 
appropriate) 
14.2.7.3  Aromatised wine-product 
cocktails    50 
(a)  200 
14.2.8 
Other alcoholic drinks including 
mixtures of alcoholic drinks with 
non-alcoholic drinks and spirits 
with less than 15% of alcohol 
only alcoholic drinks with 
less than 15 % of alcohol  100 
(a)  200 
16  Desserts excluding products 
covered in category 1, 3 and 4    5 
(a)  150 
17.1 
Food supplements supplied in a 
solid form including capsules and 
tablets and similar forms 
excluding chewable forms 
  10 
(a)  300 
17.2  Food supplements supplied in a 
liquid form    10 
(a)  100 
17.3  Food supplements supplied in a 
syrup-type or chewable form 
only liquid food supplements  10 
(a)  300 
N/A: not applicable 
(a): The total quantity of E 104, E 110, E 124 and the colours in Group III shall not exceed the maximum listed for Group III. 
(b): The total quantity of E 110, E 124 and the colours in Group III shall not exceed the maximum listed for Group III. 
(c): The total quantity of E 104 and E 110 and the colours in Group III shall not exceed the maximum listed for Group III. 
(d): In bitter vino E 100, E 101, E 102, E 104, E 110, E 120, E 122, E 123, E 124, E 129 are authorised individually or in 
combination. 
(e): In bitter soda E 100, E 101, E 102, E 104, E 110, E 120, E 122, E 123, E 124, E 129 are authorised individually or in 
combination. 
Sunset  Yellow  (E 110)  may  also  be  used  in  the  form  of  aluminium  lakes  (Regulation  (EC)  No 
1333/2008). 
3.3.  Reported use levels or data on analytical levels of sunset yellow  
Most food additives in the EU are authorised at a specific MPL. However, a food additive may be used 
at a lower level than the MPL. For those additives where no MPL is set and which are authorised as 
quantum  satis  (QS),  information  on  actual  use  levels  is  required  for  performing  an  exposure 
assessment. 
In the framework of Regulation (EC) No 1333/2008 on food additives and of Commission Regulation 
(EU) No 257/2010
9 regarding the re-evaluation of approved food additives, EFSA issued a public 
call
10 for food additives usage level and/or concentration data in March 2013, with deadline at the end 
of November 2013. Data on  Sunset Yellow FCF (E 110) including present use and use patterns (i.e. 
which food categories and subcategories, proportion of food within categories/subcategories in which 
it  is  used,  actual  use  levels  (typical  and  maximum  use  levels)  were  requested  from  relevant 
stakeholders. European food manufacturers, national food authorities, research institutions, academia, 
food business operators and any other interested stakeholders were invited to submit analytical data on 
Sunset Yellow FCF in foods. The data submission to EFSA followed the r equirements of the EFSA 
Guidance on Standard Sample Description for Food and Feed (EFSA, 2010). 
                                                       
9  Commission Regulation (EU) No 257/2010 of 25 March 2010 setting up a programme for the re-evaluation of approved 
food additives in accordance with Regulation (EC) No 1333/2008 of the European Parliament and of the Council on food 
additives. OJ L 80, 26.03.2010, p. 19. 
10  Call for food additives usage level and/or concentration data in food and beverages intended for human consumption. 
Published: 27 March 2013. http://www.efsa.europa.eu/en/data/call/130327.htm Reconsideration of the temporary ADI and 
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It should be noted that in 2012, following the conclusions of the EFSA Opinion on Sunset Yellow 
adopted in 2009 by the ANS Panel, the Annex II of Regulation (EC) No 1333/2008 was amended as 
regards the conditions of use and the use levels for Sunset Yellow FCF (E 110), Quinoline Yellow 
(E 104) and Ponceau 4R (E 124) (Commission Regulation (EU) No 232/2012
11). For Sunset Yellow 
FCF, MPLs, when not withdrawn (n=18), were decreased by a factor of 2 to 30, depending on the food 
category, applicable from 1 June 2013 (Table 2). 
Appendix B provides data on the use levels of Sunset Yellow FCF in foods as reported by industry and 
on analysed levels as provided by Member Sta tes. The Panel noted that usage or analytical values 
which were collected before June 2013 may not be up-to-date with regards to the amendments made in 
the legislation (i.e. in some cases result above the MPLs currently authorised for Sunset Yellow FCF). 
Summarised data on reported use levels of Sunset Yellow FCF in foods provided by industry 
Data on six out of the 41 food categories in which Sunset Yellow (E 110) is currently authorised as a 
food additive were provided to EFSA by the industry. 
Updated information on the actual use levels of Sunset Yellow FCF in foods was made available by 
FoodDrinkEurope (FDE) for the following food categories of finished products: batters (FCS Category 
6.6), Sobrasada (FCS Category 8.2.1), Casings and coatings and decorations for meat (FCS Category 
8.2.3),  Sauces  (FCS  Category  12.6),  and  flavoured  drinks  (FCS  Category  14.1.4).  Additional 
information on the usage levels of Sunset Yellow FCF in chewing gum (FCS Category 5.3) was 
provided by the International Chewing Gum Association (ICGA).  
Summarised data on concentration levels of Sunset Yellow FCF in foods provided by MS 
Additionally, analytical results from Member States were collected through the call launched by EFSA 
in March 2013. In total, 6522 analytical values were reported to EFSA. The foods analysed were 
sampled in Germany (n=3839), Austria (n=998), Slovakia (n=675), Hungary (n=371), Czech Republic 
(n=328), Ireland (n=206), Cyprus (n=77) and Spain (n=28) between the years 2001 to 2013.  
Data were mainly provided on flavoured drinks (FCS Category 14.1.4), other confectionery including 
freshening micro-sweets (excluding candied fruit and vegetables and dragées) (FCS Category 5.2), and 
alcoholic drinks (FCS Categories 14.2.4, 14.2.6, 14.2.7.2, 14.2.7.3 and 14.2.8). Analytical values in 
food categories in which Sunset Yellow FCF is not authorised (n=3148) were also provided. 
Out of the remaining samples (n=3374), 1712 were below the LOD, 388 below the LOQ, 531 were 
quantitative values (indication of absence or presence of Sunset Yellow FCF in the food) and 743 are 
numerical values. Only 42 analytical results received from the Member States regarded food items 
sampled in 2013 and only 11 were sampled after 1 June 2013. In the absence of more recent data, data 
collected before 2013 were also considered for the refined exposure assessment scenario, provided that 
the values were below the currently authorised MPLs of use of Sunset Yellow FCF. 
3.4.  Refined exposure assessment of Sunset Yellow FCF (E 110) 
3.4.1.  Food consumption data used for exposure assessment 
Since  2010,  the  EFSA  Comprehensive  European  Food  Consumption  Database  (Comprehensive 
Database) has been populated with data from national information on food consumption at a detailed 
level. Competent authorities in the European countries provide EFSA with data on the level of food 
consumption by the individual consumer from the most recent national dietary survey in their country 
                                                       
11  Commission Regulation (EU) No 232/2012 of 16 March 2012 amending Annex II to Regulation (EC) No 1333/2008 of the 
European Parliament and of the Council as regards the conditions of use and the use levels for Quinoline Yellow (E 104), 
Sunset Yellow FCF/Orange Yellow S (E 110) and Ponceau 4R, Cochineal Red A (E 124). OJ L 78, 17.3.2012, p.1. Reconsideration of the temporary ADI and 
refined exposure assessment for Sunset Yellow FCF (E 110) 
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(cf. Guidance of EFSA „Use of the EFSA Comprehensive European Food Consumption Database in 
Exposure Assessment‟ (EFSA, 2011b)). 
The food consumption data gathered by EFSA were collected using different methodologies and thus 
direct country-to-country comparison should be made with caution. 
For calculation of chronic exposure, intake statistics have been calculated based on individual average 
consumption over the total survey period excluding surveys with only one day per subject, considered 
as not adequate to assess repeated dietary exposure, as suggested by the EFSA Working Group on 
Food Consumption and Exposure (EFSA, 2011b). High level consumption was only calculated for 
those foods and population groups where the sample size was sufficiently large to allow calculation of 
the 95
th percentile (EFSA, 2011b). The Panel estimated chronic exposure for the following population 
groups: toddlers,  children,  adolescents,  adults  and the  elderly.  Calculations  were  performed  using 
individual body weights. 
Thus, for the present assessment, food consumption data were available from 26 different dietary 
surveys carried out in 17 European countries as mentioned in Table 3: 
Table 3:   Population groups considered for the exposure estimates of sunset yellow (E 110) 
Population  Age range  Countries with food consumption surveys 
covering more than one day 
Toddlers  from  12  up  to  and  including  35 
months of age 
Belgium,  Bulgaria,  Finland,  Germany,  Italy,  the 
Netherlands, Spain 
Children
12  from 36 months up to and including 
9 years of age  
Belgium,  Bulgaria,  Czech  Republic,  Denmark, 
Finland,  France,  Germany,  Greece,  Italy,  Latvia, 
Netherlands, Spain, Sweden  
Adolescents  from  10  up  to  and  including  17 
years of age  
Belgium,  Cyprus,  Czech  Republic,  Denmark, 
France, Germany, Italy, Latvia, Spain, Sweden 
Adults  from  18  up  to  and  including  64 
years of age 
Belgium,  Czech  Republic,  Denmark,  Finland, 
France,  Germany,  Hungary,  Ireland,  Italy,  Latvia, 
Netherlands, Spain, Sweden, UK  
The elderly
12   from 65 years of age and older  Belgium,  Denmark,  Finland,  France,  Germany, 
Hungary, Italy 
 
Consumption records were codified according to the FoodEx classification system (EFSA, 2011c). 
Nomenclature from the FoodEx classification system has been linked to the Food C ategorisation 
System (FCS) as presented in the Annex II of Regulation (EC) No 1333/2008, part D, to perform 
exposure estimates. In practice, FoodEx food codes were matched to the FCS food categories and the 
exposure was calculated by multiplying MPLs and values reported in Appendix B for each food group 
with their respective consumption amount per kg body weight (bw) separately for each individual in 
the database, calculating the sum of exposure for each survey day for the individual, and then deriving 
the daily mean for the survey period. Based on the individual exposures, the mean and 95
th percentile 
exposure was calculated for the total survey population separately for each survey and for the five 
population groups described in Table 3. 
High percentile exposure was only calculated for those foods and population groups were the sample 
size was sufficiently large to allow calculation of the 95
th percentile of exposure (EFSA, 2011c). 
Therefore, in the present assessment, high levels of exposure for toddlers from Belgium, Italy and 
Spain were not included. 
 
                                                       
12  The terms “children” and “the elderly” correspond respectively to “other children” and the merge of “elderly” and “very 
elderly” in the Guidance of EFSA on the „Use of the EFSA Comprehensive European Food Consumption Database in 
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3.4.2.  Food items selected for the refined exposure assessment of Sunset Yellow FCF (E 110) 
The food categories in which the use of Sunset Yellow FCF (E 110) is authorised were selected from 
the nomenclature of the EFSA Comprehensive Database (FoodEx classification system food codes), at 
a detailed level (up to FoodEx Level 4) (EFSA, 2011c).  
Some food items are not referenced in the EFSA Comprehensive Database and therefore could not be 
taken into account in the present estimate, as described below. This results in an underestimation of 
the exposure. 
-  4.2.4.1. Fruit and vegetable preparations excluding compote, only mostarda di frutta  
-  5.4. Decorations, coatings and fillings, except fruit based fillings covered by category 4.2.4, only 
decorations, coatings and sauces, except fillings, and only fillings 
-  6.6. Batters 
-  8.2.3. Casings and coatings and decorations for meat, only decorations and coatings except 
edible external coating of pasturmas. 
For the food category 1.6.3 Other creams, only flavoured creams: the sub-group other cream is not 
distinguishable from other kinds of cream; the same applies in differentiating flavoured cream from 
plain cream. In order to avoid a large overestimation by taking into account the whole food group of 
cream and cream powder (FCS 1.6), the flavoured creams were not taken into account in the present 
estimate.  
For some other food categories, the restrictions which apply to the use of Sunset Yellow FCF could 
not be taken into account, and therefore the whole food category with the highest use level (MPL or 
reported)  was  considered  for  the  exposure  estimates  as  described  below.  This  results  in  an 
overestimation of the exposure: 
-  9.3. Fish roe, except Sturgeons' eggs (Caviar): this exception could not be taken into account 
in the present exposure assessment, since no distinction is made in the FoodEx nomenclature 
between sturgeons‟ eggs and other fish eggs.  
-  14.2.3. Cider and perry: no distinction was possible between cider and cidre bouché.  
-  14.2.7.1.  Aromatised  wines  and  14.2.7.2.  Aromatised  wine-based  drinks:  no distinction  is 
possible between americano and other products and bitter soda and other products of each 
food category.  
3.5.  Dietary exposure assessment 
3.5.1.  Exposure to Sunset Yellow FCF (E 110) from its use as food additive 
Exposure to Sunset Yellow FCF (E 110) from its use as a food additive was calculated using MPLs as 
listed in Table 2 and using reported use level as listed in Appendix B. The Panel noted that these 
exposure estimates should be considered conservative, as it is assumed that all processed foods can 
contain Sunset Yellow at the MPLs or at the maximum reported use levels in all food categories in 
which it is authorised. 
Table 4 summarises the estimated exposure to Sunset Yellow from its use as a food additive of all five 
population groups. Detailed results by age class and survey are presented in Appendix C. Reconsideration of the temporary ADI and 
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Table 4:   Summary of anticipated exposure to Sunset Yellow FCF (E 110) from its use as a food 
additive using MPLs and reported use levels in five population groups (min-max across 
the dietary surveys in mg/kg bw/day) 
  Toddlers  Children  Adolescents  Adults  The elderly  
(12-35 months)  (3-9 years)  (10-17 years)  (18-64 years)  (>65 years) 
Estimated exposure 
using MPLs 
  Mean  
  High level
13 
 
 
0.02-0.4 
0.1-0.6 
 
 
0.03-0.3 
0.1-0.8 
 
 
0.03-0.2 
0.1-0.5 
 
 
0.01-0.1 
0.1-0.4 
 
 
<0.01-0.03 
0.02-0.1 
Estimated exposure 
using reported use 
levels 
  Mean  
  High level
13 
 
 
 
0.01-0.3 
0.02-0.6 
 
 
 
0.02-0.3 
0.1-0.7 
 
 
 
0.03-0.2 
0.1-0.4 
 
 
 
0.01-0.1 
0.1-0.4 
 
 
 
<0.01-0.02 
0.02-0.1 
 
3.5.2.  Main food categories contributing to exposure to Sunset Yellow FCF (E 110) 
Table 5:   Main food categories contributing to exposure to Sunset Yellow FCF using MPLs (> 5 % 
to  the  total  mean  exposure)  and  number  of  surveys  in  which  each  food  category  is 
contributing 
FCS 
Category 
Number 
Foods 
Toddlers  Children  Adolescents  Adults  The elderly 
range of % contribution to the total exposure  
(Number of Surveys)
(a) 
1.4 
Flavoured fermented milk 
products including  
heat-treated products 
8.7 – 74.0 
(6) 
5.3 – 20.2 
(12) 
5.2 -8.5 
(3) 
7.2– 12.2 
(3) 
6.7 – 18.6 
(4) 
5.2 
Other confectionery 
including breath freshening 
microsweets 
5.1-8.1 
(5) 
6.0-17.7 
(9) 
7.5-8.2 
(4) 
5.8 – 11.3 
(3) 
5.1 – 7.0 
(3) 
9.3  Fish roe   
5.6 
(1)   
6.5 
(1) 
5.6 
(1) 
12.4  Mustard         
5.1 
(1) 
12.9 
Protein products, excluding 
products covered in  
category 1.8 
       
6.2 
(1) 
14.1.4  Flavoured drinks 
24.4 – 88.9 
(6) 
60.5 – 95.0 
(15) 
81.3 – 94.4 
(12) 
47.3 – 91.0 
(15) 
20.7 – 88.8 
(7) 
14.2  Alcoholic beverages     
9.0 
(1) 
5.6 – 41.0 
(12) 
15.1 – 53.2 
(6) 
16 
Desserts excluding products 
covered in category 1, 3  
and 4 
7.0 – 20.8 
(2) 
5.0 -7.4 
(2)     
6.7 
(1) 
(a): The total number of surveys may be greater than the total number of countries as listed in Table 3, as some countries 
submitted more than one survey for a specific age range. 
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3.5.3.  Main food  categories  contributing  to  exposure  of  Sunset  Yellow FCF (E 110)  using 
reported use levels or analytical levels 
Table 6:   Main food categories contributing to exposure to Sunset Yellow FCF using reported use 
levels or reported data on analytical levels (> 5 % to the total mean exposure) and number 
of surveys in which each food category is contributing 
FCS 
Category 
Number 
Foods 
Toddlers  Children  Adolescents  Adults  The elderly 
range of % contribution to the total exposure  
(Number of Surveys)
(a) 
5.2 
Other confectionery 
including breath freshening 
microsweets 
7.7-22.3 
(6) 
6.6-22.5 
(9) 
5.0-8.5 
(6) 
5.0 – 17.0 
(4) 
7.0 – 13.6 
(3) 
9.3  Fish roe         
5.0 
(1) 
14.1.4  Flavoured drinks 
81.4 – 97.7 
(6) 
76.7 – 96.5 
(15) 
89.1 – 98.6 
(12) 
71.0 – 98.2 
(15) 
42.3 – 97.2 
(7) 
14.2  Alcoholic beverages       
5.1 – 22.7 
(8) 
5.9 – 40.8 
(6) 
16 
Desserts excluding products 
covered in category 1, 3  
and 4 
7.6 – 77.7 
(2) 
5.3 -7.0 
(2)     
11.8 
(1) 
(a): The total number of surveys may be greater than the total number of countries as listed in Table 3, as some countries 
submitted more than one survey for a specific age range. 
3.6.  Uncertainty analysis 
Uncertainties in the exposure assessment of Sunset Yellow FCF (E 110) have been discussed above. 
According to the guidance provided in the EFSA opinion related to uncertainties in dietary exposure 
assessment  (EFSA,  2007),  the  following  sources  of  uncertainties  have  been  considered  and 
summarised below: 
Table 7:   Qualitative evaluation of influence of uncertainties 
Sources of uncertainties  Direction
(a) 
Consumption data: different methodologies / representativeness / under 
reporting / misreporting / no portion size standard  +/- 
Use of data from food consumption survey of few days to estimate  
long-term (chronic) exposure  + 
Correspondence of reported use levels to the food items in the EFSA 
Consumption Database: uncertainties on which precise types of food the 
use levels refer. 
+/- 
Use of the FAIM tool nomenclature (FoodEx level 2) for some food 
categories   + 
Occurrence data: maximum reported use levels considered applicable for 
all items within entire food category, exposure calculations based on the 
maximum levels (permitted and reported use from industries or analytical 
from MS) 
+ 
Uncertainty in possible national differences in use levels of food 
categories, concentration data not fully representative of foods on the EU 
market 
+/- 
 (a):  +  =  uncertainty  with  potential  to  cause  over-estimation  of  exposure;  -  =  uncertainty  with  potential  to  cause 
underestimation of exposure. 
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4.  Discussion  
In  2009,  the  ANS  Panel  requested  a  28-day  study  with  Sunset  Yellow  FCF  to  be  performed,  in 
accordance  with  OECD  guidelines,  and  with  well-defined  material,  in  order  to  clarify  the 
histopathological changes in the testes and the changes in the blood lipid profile observed by Mathur 
el al. (2005a, 2005b) in rats, after 90-day dietary exposure to dose levels equivalent to 250 and 1500 
mg  Sunset  Yellow  FCF/kg  bw/day.  Furthermore,  the  test  material in  the  Mathur  studies  was  not 
characterised and was bought on the local market. A 28-day study was considered sufficient to study 
the effects on the testis, as no effects on fertility in a reproductive toxicity study in rats, and no 
relevant histopathological changes were reported in long-term studies in mice and rats (EFSA ANS 
Panel, 2009). The Panel noted that a 28-day study would also be sufficient for considering the effects 
reported on the blood lipid profile. 
The results reported by Mathur et al. (2005a, 2005b) on lipid profile and testes histopathology were 
not confirmed in a dietary 28-day study in male Hsd:SD® rats performed by Product Safety Labs 
(2012) according the current OECD guidelines and with levels of up to 18 000 mg Sunset Yellow 
FCF/kg diet (equivalent to 1 475 mg/kg bw/day). The Panel agreed with the authors of the 28-day 
study that the NOAEL of this study was 18 000 mg/kg diet (equivalent to 1 475 mg/kg bw/day), the 
highest dose level tested. The Panel noted that the material tested in this 28-day study met the EU 
specifications for Sunset Yellow FCF as a food additive. The Panel, based on the data described in its 
2009 opinion and the results from this new 28-day study, concluded that the findings of the Mathur 
studies (2005a, 2005b) should be disregarded for the risk assessment of Sunset Yellow FCF. 
The ANS Panel noted that in 2011 JECFA withdrew the previously set ADI for Sunset Yellow FCF, 
and established a new ADI of 0-4 mg/kg bw/day (JECFA, 2011). This latest evaluation performed by 
JECFA encompassed previously reviewed data, published information that had become available since 
Sunset  Yellow  FCF  was  last  considered  by  the  Committee,  and  a  comprehensive  review  of  one 
unpublished long-term feeding study in mice and two studies in rats provided by the United States 
Food and Drug Administration (FDA).  
The  Panel  evaluated  the  above  mentioned  long-term  feeding  studies  and  concluded  that  no 
carcinogenic potential of Sunset Yellow FCF/ FD&C Yellow No. 6 was observed in mice and rats. 
Based on the occurrence of the adverse effect on pup body weight gain, observed during the last part 
of the lactation in a long-term rat study in the group fed 1.5 % FD&C Yellow No. 6 in the diet, and 
described in the full reports provided by the FDA, the Panel agreed with JECFA that the NOAEL for 
this study is 0.75% (equivalent to 375 mg/kg bw/day). The Panel considered that, this NOAEL being 
obtained from a long-term study including an in utero phase, an uncertainty factor of 100 can be 
applied  for  the  derivation  of  a  new  ADI  of  4  mg/kg  bw/day.  The  Panel  noted  that  in  its  latest 
evaluation of Sunset Yellow FCF, JECFA reached similar conclusions (JECFA, 2011).  
The following additional studies were detected in an extensive literature search which was performed 
on three electronic databases (PubMed, Web of Science, Toxnet) covering the time span between 
approximately one year before the adoption of the opinion of the ANS Panel (EFSA ANS Panel, 2009) 
(i.e. from 1 November 2008 until 31 December 2013), aiming to retrieve any relevant toxicological 
data that should be taken into account for the current opinion. 
No new data on genotoxicity were retrieved, in addition to those already considered in the statement 
on Allura Red AC and other structurally related sulphonated mono azo dyes  (EFSA ANS Panel, 
2013). 
A study was carried out to investigate the effect of oral administration of Amaranth, Sunset Yellow 
FCF and Curcumin on immunological responses (Hashem et al., 2010). Sunset Yellow (315 mg/kg 
bw/day) was administered by gavage to female Sprague Dawley albino rats for 4 weeks. The authors 
stated that Sunset Yellow used at a dose of 315 mg/kg bw/day exerted a depressing effect on the 
cellular, but not humoral, immune response. The Panel noted that this study was conducted with Reconsideration of the temporary ADI and 
refined exposure assessment for Sunset Yellow FCF (E 110) 
 
EFSA Journal 2014;12(7):3765    25 
locally sourced uncharacterised material of unknown purity and did not consider this study suitable for 
risk assessment. 
Oestrogenic activity of Sunset Yellow FCF was demonstrated in an in vitro model system (Axon et al., 
2012). According to EFSA‟s Scientific Opinion on the hazard assessment of endocrine disruptors 
(EFSA SC, 2013) “the fact that a substance in an in vitro assay is binding to an endocrine receptor, 
then interfering with the intracellular messenger system connecting receptor to target, or resulting in 
an  endocrine-related  response  in  a  target  cell,  must  be  taken  as  strong  indication  for  endocrine 
activity. If a suitable animal model provides further indication for an endocrine-related adverse effect, 
this substance should be considered an endocrine disruptor”. However, in long-term studies including 
an in utero phase in mice and rats, no effects on endocrine and reproductive organs were observed. 
Therefore, the results of this in vitro study were not further considered in the risk assessment. 
A  refined  exposure  assessment  for  Sunset  Yellow  FCF  (E 110)  has  been  performed  taking  into 
consideration the MPLs of use currently authorised in Annex II of Regulation (EC) No 1333/2008. 
Overall, exposure estimates for Sunset Yellow FCF (E 110) based on the currently authorised MPLs of 
use in foods are well below the new ADI of 4 mg/kg bw/day, established by the ANS Panel, for all 
population groups.  
The  results  of  the  present  exposure  assessment  are  much  lower  compared  to  the  ones  from  the 
exposure assessment (around up to 4-8 times below depending on the population group) performed by 
the ANS Panel in 2009 (EFSA ANS Panel, 2009) for all population groups. This is due to the fact that 
in 2012, the Annex II of Regulation (EC) No 1333/2008 was amended as regards the conditions of use 
and the use levels for Sunset Yellow FCF (E 110) (Commission Regulation (EU) No 232/2012), where 
MPLs (for which not withdrawn, n=18) were decreased by a factor of 2 to 30. This is also due to a 
more refined exposure assessment being performed, taking into account the restrictions/exceptions 
listed in Annex II of Regulation (EC) No 1333/2008, the use of the EFSA Comprehensive Database 
(FoodEx) system allowing the selection of foods at the level of food items, and excluding the non-
relevant food subgroups from the intake calculations. 
For children and toddlers, the present exposure estimates were of the same magnitude when compared 
with  the  exposure  estimates  obtained  in  the  refined  exposure  assessment  of  Sunset  Yellow  FCF 
performed by EFSA in 2011. 
Updated information on the actual use levels of Sunset Yellow FCF in foods was made available by 
the  industry  for  few  of  the  food  categories  in  which  this  food  additive  is  authorised.  However, 
concentration data on Sunset Yellow FCF in foods provided by Member States were in their majority 
collected before June 2013 and therefore may not be up-to-date, as mentioned above. 
CONCLUSIONS  
The  newly  submitted  data  from  the  28-day  toxicity  study  and  the  overall  available  toxicological 
database on Sunset Yellow, including long-term studies, provides a basis to revise the established 
temporary ADI. Based on the NOAEL of 375 mg/kg bw/day from the long-term feeding study in rats, 
and  an  uncertainty  factor  of  100,  a  new  ADI  for  Sunset  Yellow  FCF  of  4  mg/kg bw/day  was 
established by the ANS Panel.  
The Panel noted that exposure estimates for Sunset Yellow FCF based both on the currently authorised 
MPLs  and  reported  use  levels  provided  are  well  below  the  new  ADI  of  4  mg/kg  bw/day  for  all 
population groups. 
Overall, the Panel concluded that, using data provided by the food industry and Member states, the 
reported uses and use levels of Sunset Yellow FCF (E 110) would not be of safety concern.  Reconsideration of the temporary ADI and 
refined exposure assessment for Sunset Yellow FCF (E 110) 
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APPENDICES  
Appendix A. Search strategies used for updated extensive literature searches 
PubMed  
Search strategy on Pubmed 
Experimental toxicokinetics and toxicodynamic data 
1.  “Sunset yellow FCF” OR “FD and C Yellow No. 6” [Supplementary Concept] OR “C.I. 
15-985” OR “sunset yellow” OR “F D and C Yellow #6” OR “gelborange S” OR “C.I. 
food yellow 3” OR “L-orange 2” OR “orange no.2” OR “E-110” 
234 
2.  #1 Filters: Publication date from 2008/11/01 to 2013/12/31  77 
3.  "toxicity tests"[Mesh] OR "toxicology"[Mesh] OR carcinogenicity[All Fields] OR 
("neurotoxicity syndromes"[MeSH Terms] OR ("neurotoxicity"[All Fields] AND 
"syndromes"[All Fields]) OR "neurotoxicity syndromes"[All Fields] OR 
"neurotoxicity"[All Fields]) OR immunotoxicity[All Fields] OR "endocrine 
disruption"[All Fields] OR "Toxic Actions"[Mesh] OR (toxic[All Fields] AND 
effect[All Fields]) OR (toxic[All Fields] AND effects[All Fields]) OR 
toxicodynamic[All Fields] OR ("toxicity"[Subheading] OR "toxicity"[All Fields]) OR 
toxicological[All Fields] OR ("pharmacokinetics"[Subheading] OR 
"pharmacokinetics"[All Fields] OR "pharmacokinetics"[MeSH Terms]) OR 
("pharmacokinetics"[Subheading] OR "pharmacokinetics"[All Fields] OR 
"toxicokinetics"[All Fields] OR "pharmacokinetics"[MeSH Terms] OR 
"toxicokinetics"[All Fields]) OR (pharmacodynamic[All Fields] OR 
pharmacodynamic'[All Fields] OR pharmacodynamical[All Fields] OR 
pharmacodynamically[All Fields] OR pharmacodynamices[All Fields] OR 
pharmacodynamicque[All Fields] OR pharmacodynamics[All Fields] OR 
pharmacodynamics'[All Fields] OR pharmacodynamics,[All Fields]) OR 
("behaviour"[All Fields] OR "behavior"[MeSH Terms] OR "behavior"[All Fields]) OR 
"weight loss"[All Fields] OR "blood changes"[All Fields] OR ("reproduction"[MeSH 
Terms] OR "reproduction"[All Fields] OR "reproductive"[All Fields]) OR "DNA 
damages"[All Fields] OR ("neoplasms"[MeSH Terms] OR "neoplasms"[All Fields] OR 
"cancer"[All Fields]) OR ("tumour"[All Fields] OR "neoplasms"[MeSH Terms] OR 
"neoplasms"[All Fields] OR "tumor"[All Fields]) OR genotoxic[All Fields] 
6 306 704 
4.  #2 AND #3  19 
Date of the search: January 13, 2014. Reconsideration of the temporary ADI and 
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Web of Science 
Search strategy on Web of Science 
Experimental toxicokinetics and toxicodynamic data 
1.  TS=("Sunset yellow FCF" OR “FD and C Yellow No. 6” OR “C.I. 15-985” OR “sunset 
yellow” OR “F D and C Yellow #6” OR “gelborange S” OR “C.I. food yellow 3” OR 
“L-orange 2” OR “orange no.2” OR “E-110”) 
594 
2.  #1 Filters: Publication date from 2008 to 2013  257 
3.  TS=("Toxicity Tests" OR “Tests, Toxicity” OR “Test, Toxicity” OR “Toxicity Test” 
OR "Toxicology" OR "Toxic Actions" OR “Actions, Toxic” OR “toxic effect” OR 
“toxic effects” OR "toxicity" OR “toxicological” OR “toxicodynamic” OR 
“toxicodynamical” OR “toxicodynamics” OR “pharmacodynamic*” OR 
"pharmacokinetics" OR "toxicokinetics" OR “Carcinogenicity” OR “Neurotoxicity” 
OR “Neurotoxicity Syndrome” OR “Syndrome, Neurotoxicity” OR “Syndromes, 
Neurotoxicity” OR “Neurotoxic Disorders” OR “Neurotoxic Disorder” OR “Poisoning, 
Nervous System” OR “Nervous System Poisonings” OR “Poisonings, Nervous System” 
OR “Nervous System Poisoning” OR “Encephalopathy, Toxic” OR “Encephalopathies, 
Toxic” OR “Toxic Encephalopathies” OR “Toxic Encephalopathy” OR “Toxic 
Encephalitis” OR “Encephalitides, Toxic” OR “Encephalitis, Toxic” OR “Toxic 
Encephalitides” OR “Immunotoxicity” OR "weight loss" OR "blood changes" OR 
"reproduction" OR "reproductive" OR "endocrine disruption" OR "DNA damages" OR 
"neoplasms" OR “Neoplasm” OR “Tumors” OR “Tumor” OR “tumour” OR 
“Neoplasia” OR “Cancer” OR “Cancers” OR “genotoxic*” OR “behavior*” OR 
“behavior” OR “behaviour”) 
4 646 074 
4.  #2 AND #3  49 
Date of the search: January 13, 2014. 
 
ToxNet 
The searches performed in ToxNet on January 13, 2014 did not record additional studies compared to 
the PubMed and Web of Science databases. 
PubMed  
Search strategy on Pubmed 
Human exposure and effect data 
1.  “Sunset yellow FCF” OR “FD and C Yellow No. 6” [Supplementary Concept] OR “C.I. 
15-985” OR “sunset yellow” OR “F D and C Yellow #6” OR “gelborange S” OR “C.I. 
food yellow 3” OR “L-orange 2” OR “orange no.2” OR “E-110” 
234 
2.  #1 Filters: Publication date from 2008/11/01 to 2013/12/31  77 
3.  Biomarkers OR biological markers OR "biological markers"[Mesh] OR Markers, 
Biological OR Marker, Biological OR Biological Marker OR Biologic Marker OR 
Marker, Biologic OR Biologic Markers OR Markers, Biologic OR Markers, Clinical 
OR Clinical Markers OR Marker, Clinical OR Clinical Marker OR Markers, 
Immunologic OR Marker, Immunologic OR Immune Markers OR Markers, Immune 
OR Immune Marker OR Marker, Immune OR Immunologic Markers OR Immunologic 
Marker OR Viral Markers OR Viral Marker OR Marker, Viral OR Markers, Viral OR 
Serum Markers OR Markers, Serum OR Serum Marker OR Marker, Serum OR 
Surrogate Endpoints OR Endpoints, Surrogate OR Surrogate End Points OR End 
Points, Surrogate OR Surrogate Endpoint OR Endpoint, Surrogate OR Surrogate End 
Point OR End Point, Surrogate OR Surrogate Markers OR Markers, Surrogate OR 
Surrogate Marker OR Marker, Surrogate OR Biochemical Marker OR Marker, 
Biochemical OR Markers, Biochemical OR Biochemical Markers OR Markers, 
Laboratory OR Laboratory Markers OR Marker, Laboratory OR Laboratory Marker 
791 187 
4.  Epidemiology OR "epidemiology" [Subheading] OR epidemics OR frequency OR 
surveillance OR morbidity OR occurrence OR outbreaks OR prevalence OR endemics 
OR incidence OR epidemiologic study OR Epidemiological Studies OR 
Epidemiological Study OR Studies, Epidemiological OR Study, Epidemiological OR 
Studies, Epidemiologic OR Epidemiologic Studies OR Study, Epidemiologic 
3 850 298 Reconsideration of the temporary ADI and 
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5.  "Case Reports" [Publication Type] OR Case Study OR Case Studies OR case history 
OR healthy volunteer* OR Case Histories OR “clinical studies” OR “clinical trials” 
[Publication type] 
1 824 104 
6.  #3 OR #4 OR #5  6 001 707 
7.  #2 AND #6  9 
8.  #7 NOT (“Animals” NOT “humans”)  7 
Date of the search: January 13, 2014. 
 
Web of Science 
Search strategy on Pubmed 
Human exposure and effect data 
1.  TS=("Sunset yellow FCF" OR “FD and C Yellow No. 6” OR “C.I. 15-985” OR “sunset 
yellow” OR “F D and C Yellow #6” OR “gelborange S” OR “C.I. food yellow 3” OR 
“L-orange 2” OR “orange no.2” OR “E-110”) 
594 
2.  #1 Filters: Publication date from 2008 to 2013  257 
3.  TS=(Biomarkers OR biological markers OR "biological markers" OR Markers, 
Biological OR Marker, Biological OR Biological Marker OR Biologic Marker OR 
Marker, Biologic OR Biologic Markers OR Markers, Biologic OR Markers, Clinical 
OR Clinical Markers OR Marker, Clinical OR Clinical Marker OR Markers, 
Immunologic OR Marker, Immunologic OR Immune Markers OR Markers, Immune 
OR Immune Marker OR Marker, Immune OR Immunologic Markers OR Immunologic 
Marker OR Viral Markers OR Viral Marker OR Marker, Viral OR Markers, Viral OR 
Serum Markers OR Markers, Serum OR Serum Marker OR Marker, Serum OR 
Surrogate Endpoints OR Endpoints, Surrogate OR Surrogate End Points OR End 
Points, Surrogate OR Surrogate Endpoint OR Endpoint, Surrogate OR Surrogate End 
Point OR End Point, Surrogate OR Surrogate Markers OR Markers, Surrogate OR 
Surrogate Marker OR Marker, Surrogate OR Biochemical Marker OR Marker, 
Biochemical OR Markers, Biochemical OR Biochemical Markers OR Markers, 
Laboratory OR Laboratory Markers OR Marker, Laboratory OR Laboratory Marker) 
267 619 
4.  TS=(Epidemiology OR epidemics OR frequency OR surveillance OR morbidity OR 
occurrence OR outbreaks OR prevalence OR endemics OR incidence OR 
epidemiologic study OR Epidemiological Studies OR Epidemiological Study OR 
Studies, Epidemiological OR Study, Epidemiological OR Studies, Epidemiologic OR 
Epidemiologic Studies OR Study, Epidemiologic) 
2 826 641 
5.  TS=("Case Reports" OR Case Study OR Case Studies OR case history OR healthy 
volunteer* OR Case Histories OR “clinical studies” OR “clinical trials”) 
1 399 086 
6.  #3 OR #4 OR #5  4 134 605 
7.  #2 AND #6  27 
8.  #7 NOT TS=(“animals” NOT “humans”)  27 
Date of the search: January 13, 2014. 
 
ToxNet 
The searches performed in ToxNet on January 13, 2014 did not record additional studies compared to 
the PubMed and Web of Science databases. 
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Appendix B. Summary of usage levels reported by industry and analytical data reported by Member States (mg/kg) on Sunset Yellow FCF (E 110)  
FCS 
No  Food category 
MPL (mg/l  
or mg/kg as 
appropriate) 
Restrictions/ 
exceptions 
Reported usage levels  Concentration level from Member States 
Data 
used in 
the 
refined 
scenario 
 
Maximum reported use levels  
(mg/l or mg/kg as appropriate) 
Positive levels 
(mg/kg) 
Total 
number of 
data 
FDE  ICGA  Number 
of data  min  median  mean  p95  max 
n  Typical   Maximum   n  Typical   Maximum  
1.4 
Flavoured 
fermented milk 
products including 
heat treated 
products 
5                                           
No 
data/not 
taken 
into 
account 
1.6.3  Other creams  5  only flavoured 
creams                                        
No data/ 
sub food 
group 
not in 
FoodEx 
4.2.4.1 
Fruit and vegetable 
preparations 
excluding compote 
35  only mostarda 
di frutta                                         Not in 
FoodEx 
5.2 
Other confectionery 
including breath 
refreshening 
microsweets 
35 
except candied 
fruit and 
vegetables; 
traditional sugar 
coated nut- or 
cocoa-based 
confectionery of 
almond shape or 
host shape, 
typically longer 
than 2 cm and 
typically 
consumed at 
celebratory 
occasions, i.e. 
weddings, 
communion, etc.  
                     227  0.1  6.2  9.1  30.0  35.0  35 
5.2 
Other confectionery 
including breath 
refreshening 
microsweets 
10 
only candied 
fruit and 
vegetables 
                     5  1.3  5.0  4.8  8.5  8.5  8.5 Reconsideration of the temporary ADI and 
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FCS 
No  Food category 
MPL (mg/l  
or mg/kg as 
appropriate) 
Restrictions/ 
exceptions 
Reported usage levels  Concentration level from Member States 
Data 
used in 
the 
refined 
scenario 
 
Maximum reported use levels  
(mg/l or mg/kg as appropriate) 
Positive levels 
(mg/kg) 
Total 
number of 
data 
FDE  ICGA  Number 
of data  min  median  mean  p95  max 
n  Typical   Maximum   n  Typical   Maximum  
5.2 
Other confectionery 
including breath 
refreshening 
microsweets 
50 
only traditional 
sugar coated 
nut- or cocoa-
based 
confectionery of 
almond shape or 
host shape, 
typically longer 
than 2 cm and 
typically 
consumed at 
celebratory 
occasions, i.e. 
weddings, 
communion, etc.  
                     11  0.2  7.4  10.9  30.5  30.5  30.5 
5.3  Chewing gum  10    1        1  50  50*  12  0.8  5.4  5.6  10.0  10.0  10 
5.4 
Decorations, 
coatings and fillings, 
except fruit based 
fillings covered by 
category 4.2.4  
35 
only 
decorations, 
coatings and 
sauces, except 
fillings 
                     3  23.8  30.9  29.7  34.4  34.4  Not in 
FoodEx 
5.4 
Decorations, coatings 
and fillings, except 
fruit based fillings 
covered by category 
4.2.4  
35  only fillings                                         Not in 
FoodEx 
6.6  Batters  35     1  1  11  11                             Not in 
FoodEx 
8.2.1  Non heat-treated 
processed meat  15  only sobrasada  1  1  15  15                             15 
8.2.3 
Casings and 
coatings and 
decorations for meat 
35 
only decorations 
and coatings 
except edible 
external coating 
of pasturmas 
1  1 NP  0.3  0.3                             Not in 
FoodEx 
9.2. 
Processed fish and 
fishery products 
including mollusks 
and crustaceans 
200 
 only in salmon 
substitutes 
based on 
Theragra 
chalcogramma 
                     69  46.0  113.1  120.4  195.0  198.4  198.4 Reconsideration of the temporary ADI and 
refined exposure assessment for Sunset Yellow FCF (E 110) 
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FCS 
No  Food category 
MPL (mg/l  
or mg/kg as 
appropriate) 
Restrictions/ 
exceptions 
Reported usage levels  Concentration level from Member States 
Data 
used in 
the 
refined 
scenario 
 
Maximum reported use levels  
(mg/l or mg/kg as appropriate) 
Positive levels 
(mg/kg) 
Total 
number of 
data 
FDE  ICGA  Number 
of data  min  median  mean  p95  max 
n  Typical   Maximum   n  Typical   Maximum  
and Pollachius 
virens  
9.3  Fish roe  200 
except 
Sturgeons' eggs 
(Caviar) 
                     15  8.0  88.0  83.7  122.0  122.0  122.0 
12.4  Mustard  50                          1  8.3  8.3  8.3  8.3  8.3  8.3 
12.6  Sauces  30  only in pickles 
and piccalilli   1  1  17  20          1  12.7  12.7  12.7  12.7  12.7  20.0 
12.9 
Protein products, 
excluding products 
covered in category 
1.8 
20 
only meat and 
fish analogues 
based on 
vegetable 
proteins 
                                 
No 
data/not 
taken 
into 
account  
13.2 
Dietary foods for 
special medical 
purposes defined in 
Directive 1999/21/EC 
(excluding products 
from food category 
13.1.5) 
10                                           
No 
data/not 
taken 
into 
account 
13.3 
Dietary foods for 
weight control diets 
intended to replace 
total daily food 
intake or an 
individual meal (the 
whole or part of the 
total daily diet) 
10                                           
No 
data/not 
taken 
into 
account 
14.1.4  Flavoured drinks  20 
excluding 
chocolate milk 
and malt 
products 
31  31  10  20        147  0.2  5.1  6.4  16.0  19.3  20.0 
14.2.3  Cider and perry  10  excluding cidre 
bouché                                        
No 
data/not 
taken 
into 
account 
14.2.4  Fruit wine and 
made wine  10                                           
 No 
data/not 
taken Reconsideration of the temporary ADI and 
refined exposure assessment for Sunset Yellow FCF (E 110) 
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FCS 
No  Food category 
MPL (mg/l  
or mg/kg as 
appropriate) 
Restrictions/ 
exceptions 
Reported usage levels  Concentration level from Member States 
Data 
used in 
the 
refined 
scenario 
 
Maximum reported use levels  
(mg/l or mg/kg as appropriate) 
Positive levels 
(mg/kg) 
Total 
number of 
data 
FDE  ICGA  Number 
of data  min  median  mean  p95  max 
n  Typical   Maximum   n  Typical   Maximum  
into 
account 
14.2.6 
Spirit drinks as 
defined in 
Regulation (EC) No 
110/2008  
100 
except: spirit 
drinks as 
defined in 
Article 5(1) and 
sales 
denominations 
listed in Annex 
II, paragraphs 1-
14 of 
Regulation (EC) 
No 110/2008 
and spirits 
(preceded by the 
name of the 
fruit) obtained 
by maceration 
and distillation, 
Geist (with the 
name of the fruit 
or the raw 
material used), 
London Gin, 
Sambuca, 
Maraschino, 
Marrasquino or 
Maraskino and 
Mistrà 
                     12  0.2  1.9  7.3  33.6  33.6  33.6 
14.2.7.1  Aromatised wines  50 
except 
americano, 
bitter vino 
                                      
23.0 
14.2.7.1  Aromatised wines  50  only bitter vino                                        
14.2.7.2  Aromatised wine-
based drinks  50 
except bitter 
soda, sangria, 
claria, zurra 
                                      
14.2.7.2  Aromatised wine-
based drinks  50  only bitter soda                                        
14.2.7.3  Aromatised wine-
product cocktails  50                          3  8.6  21.7  17.8  23.0  23.0 Reconsideration of the temporary ADI and 
refined exposure assessment for Sunset Yellow FCF (E 110) 
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FCS 
No  Food category 
MPL (mg/l  
or mg/kg as 
appropriate) 
Restrictions/ 
exceptions 
Reported usage levels  Concentration level from Member States 
Data 
used in 
the 
refined 
scenario 
 
Maximum reported use levels  
(mg/l or mg/kg as appropriate) 
Positive levels 
(mg/kg) 
Total 
number of 
data 
FDE  ICGA  Number 
of data  min  median  mean  p95  max 
n  Typical   Maximum   n  Typical   Maximum  
14.2.8 
Alcoholic 
beverages, 
including alcohol-
free and low-
alcohol 
counterparts 
100 
only alcoholic 
drinks with less 
than 15 % of 
alcohol 
                     70  0.4  4.1  6.8  22.7  37.8  37.8 
16 
Desserts excluding 
products covered in 
category 1, 3 and 4 
5                          2  2.0  3.2  3.2  4.3  4.3  4.3 
17.1 
Food supplements 
supplied in a solid 
form including 
capsules and tablets 
and similar forms 
excluding chewable 
forms 
10                         
                 
No 
data/not 
taken 
into 
account  17.2 
Food supplements 
supplied in a liquid 
form 
10                         
17.3 
Food supplements 
supplied in a syrup-
type or chewable 
form 
10                         
 
(a):  This  information  had  been  collected  in  the  course  of  2012  and  the  value  provided  resulted  to  be  above  the  MPL  currently  authorised  for  Sunset  Yellow  FCF  in  chewing  gum.Reconsideration of the temporary ADI and 
refined exposure assessment for Sunset Yellow FCF (E 110) 
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Summary of total estimated exposure to Sunset Yellow FCF (E 110) using MPLs and reported 
use levels per age class and survey: mean and high level (mg/kg bw/day) 
  
Number 
of 
subjects 
MPL   Reported use levels 
Mean  High level  Mean  High level 
Toddlers 
Belgium (Regional_Flanders)  36  0.37  -  0.33  - 
Bulgaria (NUTRICHILD)  428  0.05  0.25  0.05  0.25 
Germany (DONALD_2006_2008)  261  0.05  0.23  0.04  0.21 
Spain (enKid)  17  0.03  -  0.01  - 
Finland (DIPP_2003_2006)  497  0.04  0.12  0.01  0.02 
Italy (INRAN_SCAI_2005_06)  36  0.02  -  0.01  - 
Netherlands (VCP_kids)  322  0.19  0.61  0.15  0.61 
Children 
Belgium (Regional_Flanders)  625  0.29  0.76  0.26  0.72 
Bulgaria (NUTRICHILD)  433  0.10  0.39  0.10  0.39 
Czech Republic (SISP04)  389  0.13  0.51  0.12  0.51 
Germany (DONALD_2006_2008)  660  0.15  0.48  0.14  0.47 
Denmark (Danish_Dietary_Survey)  490  0.19  0.42  0.18  0.41 
Spain (enKid)  156  0.07  0.31  0.06  0.29 
Spain (NUT_INK05)  399  0.06  0.22  0.05  0.21 
Finland (DIPP_2003_2006)  933  0.09  0.27  0.07  0.25 
Finland (STRIP)  250  0.14  0.36  0.13  0.35 
France (INCA2)  482  0.08  0.28  0.07  0.26 
Greece (Regional_Crete)  839  0.03  0.13  0.03  0.13 
Italy (INRAN_SCAI_2005_06)  193  0.03  0.11  0.02  0.11 
Latvia (EFSA_TEST)  189  0.06  0.25  0.06  0.25 
Netherlands (VCP_kids)  957  0.19  0.55  0.16  0.50 
Sweden (NFA)  1473  0.26  0.58  0.24  0.56 
Adolescents 
Belgium (Diet_National_2004)  584  0.15  0.45  0.15  0.42 
Cyprus (Childhealth)  303  0.03  0.12  0.03  0.11 
Czech Republic (SISP04)  298  0.12  0.39  0.11  0.37 
Germany (National_Nutrition_Survey_II)  1011  0.08  0.35  0.07  0.31 
Denmark (Danish_Dietary_Survey)  479  0.16  0.39  0.15  0.38 
Spain (AESAN_FIAB)  86  0.03  0.16  0.03  0.16 
Spain (enKid)  209  0.05  0.22  0.05  0.21 
Spain (NUT_INK05)  651  0.06  0.20  0.05  0.19 
France (INCA2)  973  0.05  0.17  0.04  0.16 
Italy (INRAN_SCAI_2005_06)  247  0.03  0.12  0.03  0.12 
Latvia (EFSA_TEST)  470  0.04  0.17  0.04  0.16 
Sweden (NFA)  1018  0.17  0.39  0.16  0.38 
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Number 
of 
subjects 
MPL   Reported use levels 
Mean  High level  Mean  High level 
Adults 
Belgium (Diet_National_2004)  1304  0.10  0.37  0.09  0.34 
Czech Republic (SISP04)  1666  0.04  0.18  0.03  0.17 
Germany (National_Nutrition_Survey_II)  10419  0.04  0.21  0.04  0.19 
Denmark (Danish_Dietary_Survey)  2822  0.07  0.21  0.06  0.20 
Spain (AESAN)  410  0.04  0.16  0.04  0.16 
Spain (AESAN_FIAB)  981  0.03  0.13  0.03  0.12 
Finland (FINDIET_2007)  1575  0.03  0.14  0.02  0.11 
France (INCA2)  2276  0.04  0.16  0.03  0.12 
United Kingdom (NDNS)  1724  0.07  0.24  0.05  0.18 
Hungary (National_Repr_Surv)  1074  0.04  0.15  0.04  0.15 
Ireland (NSIFCS)  958  0.06  0.21  0.04  0.16 
Italy (INRAN_SCAI_2005_06)  2313  0.01  0.06  0.01  0.05 
Latvia (EFSA_TEST)  1306  0.02  0.10  0.02  0.08 
Netherlands (DNFCS_2003)  750  0.13  0.37  0.12  0.36 
Sweden (Riksmaten_1997_98)  1210  0.06  0.21  0.06  0.19 
The Elderly  
Belgium (Diet_National_2004)  1230  0.03  0.12  0.02  0.11 
Germany (National_Nutrition_Survey_II)  2496  0.01  0.06  0.01  0.05 
Denmark (Danish_Dietary_Survey)  329  0.03  0.11  0.02  0.09 
Finland (FINDIET_2007)  463  0.01  0.06  0.01  0.04 
France (INCA2)  348  0.01  0.06  0.01  0.03 
Hungary (National_Repr_Surv)  286  0.03  0.09  0.02  0.09 
Italy (INRAN_SCAI_2005_06)  518  0.00  0.02  0.00  0.02 
Note: The different methodologies of European dietary surveys included in the EFSA Comprehensive Database are fully 
described in the Guidance on the use of the EFSA Comprehensive European Food Consumption Database in Exposure 
Assessment (EFSA, 2011b). A summary is available p.11, Table 1 of the guidance. Reconsideration of the temporary ADI and 
refined exposure assessment for Sunset Yellow FCF (E 110) 
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GLOSSARY AND ABBREVIATIONS 
ADI  Acceptable Daily Intake  
tADI  temporary ADI 
AFSSA  Agence Française de Sécurité Sanitaire des Aliments 
ANS Panel  Scientific Panel on Food Additives and Nutrient Sources added to Food 
ANSES  Agence nationale de sécurité sanitaire de l‟alimentation, de l‟environnement et du 
travail 
bw  Body weight 
CCMA  Certified Color Manufacturers Association 
CEPS  European Spirits Organisation 
CIAA  Confederation of the Food and Drink Industries of the EU 
EC  European Commission 
EFSA  European Food Safety Authority 
ELC  Federation of European Food Additives, Food Enzymes and Food Culture Industries 
ER  Oestrogen receptor 
EU  European Union  
EXPOCHI   Individual food consumption data and exposure assessment studies for children 
FAO  Food and Agricultural Organisation 
FCS  Food  Categorisation  System  (food  nomenclature)  presented  in  the  Annex  II  of 
Regulation (EC) No 1333/2008 
FDA  United States Food and Drug Administration 
FDE  FoodDrinkEurope 
FSA  UK Food Standards Agency 
FSAI  Food Safety Authority of Ireland 
GLP  Good Laboratory Practice 
i.p.  intraperitoneal 
JECFA  Joint FAO/WHO Expert Committee on Food Additives 
ICGA  International Chewing Gum Association 
LOD  Limit of detection 
MLR  Mixed Lymphocyte Reaction 
MPL  Maximum Permitted Level 
MS  Member States 
MTD  maximum tolerated dose 
nAChRs  nicotinic acetylcholine receptors 
NMDAR  N-methyl-D-aspartate receptors 
NOAEL  No-Observed-Adverse-Effect Level Reconsideration of the temporary ADI and 
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NTP  National Toxicology Program 
OECD  Organisation for Economic Co-operation and Development 
PI  Propidium Iodide 
SCF  Scientific Committee for Food 
SCOOP  A scientific cooperation (SCOOP) task involves coordination amongst Member States 
to provide pooled data from across the EU on particular issues of concern regarding 
food safety 
TA  transcriptional activation 
UK  United Kingdom 
UNESDA  Union of European Soft Drinks Associations 
WHO  World Health Organization 
 